Sheath apparatus and methods for delivering a closure device

Information

  • Patent Grant
  • 8579932
  • Patent Number
    8,579,932
  • Date Filed
    Tuesday, February 24, 2004
    20 years ago
  • Date Issued
    Tuesday, November 12, 2013
    11 years ago
Abstract
An apparatus for delivering a clip includes an introducer sheath including an outer surface extending between its proximal and distal ends. A clip is carried on the outer surface, e.g., on a carrier assembly that is slidable along the outer surface from the proximal end towards the distal end. A skin overlies the outer surface of the sheath and the carrier assembly that is separable from the outer surface as the carrier assembly is advanced from the proximal end towards the distal end of the sheath. During use, the distal end of the sheath is inserted into an opening through tissue, e.g., into a puncture communicating with a blood vessel. The carrier assembly is advanced towards the distal end of the sheath, causing the skin to separate from the outer surface of the elongate member, and the clip is deployed from the carrier to seal the opening.
Description
FIELD OF THE INVENTION

The present invention relates generally to apparatus and methods for closing and/or sealing openings through tissue, and more particularly to apparatus and methods for delivering a closure element for closing a puncture in a blood vessel or other body lumen formed during a diagnostic or therapeutic procedure.


BACKGROUND

Catheterization and interventional procedures, such as angioplasty or stenting, generally are performed by inserting a hollow needle through a patient's skin and muscle tissue into the vascular system. A guide wire may then be passed through the needle lumen into the patient's blood vessel accessed by the needle. The needle may be removed, and an introducer sheath may be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to a dilator. A catheter or other device may be advanced through a lumen of the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate introduction of various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss during a procedure.


Upon completion of the procedure, the devices and introducer sheath may be removed, leaving a puncture site in the vessel wall. External pressure may be applied to the puncture site until clotting and wound sealing occur. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a physician's or nurse's time. It is also uncomfortable for the patient, and requires that the patient remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.


Various apparatus have been suggested for percutaneously sealing a vascular puncture by occluding the puncture site. For example, U.S. Pat. Nos. 5,192,302 and 5,222,974, issued to Kensey et al., describe the use of a biodegradable plug that may be delivered through an introducer sheath into a puncture site. When deployed, the plug may seal the vessel and provide hemostasis. Such devices, however, may be difficult to position properly with respect to the vessel, which may be particularly significant since it is generally undesirable to expose the plug material, e.g., collagen, within the bloodstream, where it may float downstream and risk causing an embolism.


Another technique has been suggested that involves percutaneously suturing the puncture site, such as that disclosed in U.S. Pat. No. 5,304,184, issued to Hathaway et al. Percutaneous suturing devices, however, may require significant skill by the user, and may be mechanically complex and expensive to manufacture.


To facilitate positioning devices that are percutaneously inserted into a blood vessel, “bleed back” indicators have been suggested. For example, U.S. Pat. No. 5,676,974, issued to Kensey et al., discloses a bleed back lumen intended to facilitate positioning of a biodegradable plug within a puncture site. This device, however, requires that an anchor of the plug be positioned within the vessel, and therefore, may increase the risk of over-advancement of the plug itself into the vessel.


Alternatively, U.S. Pat. No. 5,674,231, issued to Green et al., discloses a deployable loop that may be advanced through a sheath into a vessel. The loop is intended to resiliently expand to engage the inner wall of the vessel, thereby facilitating holding the sheath in a desired location with respect to the vessel. The loop may also provide a support for facilitating the deployment and deflection of a surgical clip against the vessel wall. Such a device, however, may risk engagement between the loop and the surgical clip, thereby preventing the loop from being withdrawn from the vessel.


Accordingly, apparatus and methods for delivering a device for closing a vascular puncture site or other opening through tissue would be useful.


SUMMARY OF THE INVENTION

The present invention is directed to apparatus and methods for closing and/or sealing openings through tissue, e.g., into body lumens, and more particularly to apparatus and methods for delivering a vascular closure element for closing a puncture in a blood vessel formed during a diagnostic or therapeutic procedure.


In accordance with one aspect of the present invention, an apparatus is provided for delivering a closure element or other annular-shaped device into an opening through tissue, e.g., for engaging tissue adjacent the opening to close and/or seal the opening. The apparatus generally includes an elongate member including proximal and distal ends defining a longitudinal axis therebetween, and an outer surface extending between the proximal and distal ends. In one embodiment, the elongate member may be an introducer sheath that includes a lumen for advancing one or more devices into a body lumen during a procedure.


A carrier assembly may be slidable on the elongate member from the proximal end towards the distal end, the carrier assembly including a carrier member and a pusher member movable distally relative to the carrier member. A distal end of the pusher member may be disposed proximal to a distal end of the carrier member, e.g., if the pusher member has a substantially shorter length than the carrier member, thereby defining a space distal to the pusher member along an outer surface of the carrier member. An annular-shaped element, e.g., a clip or other closure device, may be received on the carrier member, the annular-shaped element being deployable from the carrier member upon distal movement of the pusher member relative to the carrier member.


Optionally, the carrier member may include one or more ramped portions, each portion defining a ramped distal surface and/or a ramped proximal surface. The closure element may include a plurality of tines extending distally, the tines being disposed proximal to the one or more ramped portions such that the ramped portions may protect the tines during advancement of the carrier assembly. In addition, the pusher member may advance the closure element over the one or more ramped portions when the carrier assembly is advanced to a distal position, e.g., for directing the tines radially outwardly to engage surrounding tissue.


A skin overlies at least a portion of the outer surface of the elongate member and the carrier assembly, the skin being separable from the outer surface of the elongate member as the carrier assembly is advanced from the proximal end towards the distal end of the elongate member. In one embodiment, the skin may include a weakened region, e.g., a thin and/or perforated region, extending axially along the skin. The weakened region may be configured to tear preferentially as the carrier assembly is advanced from the proximal end towards the distal end of the elongate member. In another embodiment, the skin may include a flap extending axially along the outer surface of the elongate member and overlying an adjacent region of the skin. The flap may be bonded to the adjacent region such that the flap may be separated from the adjacent region as the carrier assembly is advanced towards the distal end of the elongate member.


In addition or alternatively, the skin may be bonded to the outer surface of the elongate member by an adhesive. The adhesive may have sufficient adhesive strength such that the skin may be peeled away from the outer surface as the carrier assembly is advanced towards the distal end of the elongate member.


The apparatus may also include an actuator assembly including a housing extending from the proximal end of the elongate member, e.g., connectable by cooperating detents, and one or more elongate actuator elements that are movable axially relative to the housing. The actuator elements may be connected to the carrier assembly for coupling movement of the carrier assembly to the one or more actuator elements. For example, the carrier assembly and the actuator elements may include cooperating detents for coupling distal movement of the carrier assembly to the one or more actuator elements as the control member is directed distally. The cooperating detents may release the carrier member upon attaining a distal position, thereby permitting further distal movement of the pusher member to deploy the closure element from the carrier member.


During use, the distal end of the elongate member may be inserted into an opening through tissue, e.g., into a puncture communicating with an artery or other blood vessel. If the elongate member is an introducer sheath, one or more instruments may be inserted through the sheath, e.g., into a blood vessel accessed via the opening. A diagnostic and/or therapeutic procedure may be performed within a patient's body, e.g., via the blood vessel accessed via the opening. Upon completion of the procedure, any instruments may be removed from the sheath, the handle assembly may be connected to the proximal end of the elongate member, and/or an actuator may be coupled to the carrier assembly. Optionally, the distal end of the elongate member may be positioned relative to the blood vessel, e.g., using a bleedback indicator or a tactile indicator, such as an expandable obturator.


To deploy the closure element, the carrier assembly may be advanced towards the distal end of the elongate member. The carrier assembly may cause the skin to separate from the outer surface of the elongate member as the carrier assembly is advanced towards the distal end. If the skin includes a weakened region extending towards the distal end of the elongate member, the weakened region may tear preferentially as the carrier assembly is advanced towards the distal end of the elongate member. If the skin includes a flap extending axially along the outer surface of the elongate member and overlying an adjacent region of the skin, the flap may be released from the adjacent region as the carrier assembly is advanced towards the distal end of the elongate member, thereby allowing the skin to separate from the outer surface. In addition or alternatively, if the skin is bonded to the outer surface of the elongate member by an adhesive, the adhesive may have sufficient adhesive strength to release as the carrier assembly directs the skin outwardly such that the skin is separated from the outer surface as the carrier assembly is advanced towards the distal end.


As the carrier assembly is advanced, the carrier assembly may pass between the skin and the outer surface of the elongate member. Thus, if the opening through tissue extends through one or more layers of fascia or other tissue structures, the skin may facilitate advancing the carrier assembly through the layers and/or minimize the risk of the carrier assembly or the closure element catching on tissue as it is advanced towards the distal end of the elongate member.


The closure element may be deployed from the carrier assembly within the opening, e.g., by ejecting the closure element from the carrier assembly and/or by withdrawing the elongate member from the opening. With the elongate member withdrawn, the closure element may substantially close or seal the opening, e.g., to prevent blood flow therethrough, thereby allowing the opening to heal.


In accordance with another aspect of the present invention, an apparatus is provided for delivering a closure device that includes an elongate member, e.g., an introducer sheath, including proximal and distal ends defining a longitudinal axis therebetween, and an outer surface extending between the proximal and distal ends. A hub may be provided on the proximal end of the elongate member, the hub including one or more alignment tabs or spacers disposed about the periphery of the hub and/or spaced away from the outer surface of the elongate member.


A closure element, e.g., a clip, may be provided that includes a generally annular-shaped body including proximal and distal ends and a plurality of tissue engaging portions extending from the distal end. The proximal end of the closure element may be held away from the outer surface of the elongate member by the one or more spacers.


An actuator or handle assembly is provided that includes an actuator member slidable between the hub and the outer surface of the elongate member. The actuator member includes one or more elements for coupling with the closure element, whereby distal movement of the actuator member advances the closure element towards the distal end of the elongate member. In one embodiment, the hub may include an annular hub defining a passage between the annular hub and the outer surface of the elongate member, e.g., attached to the elongate member by one or more radial spokes. The actuator member may include a tubular member, e.g., defining a “C” shaped cross-section for inserting the tubular member through the passage around the one or more radial spokes.


In a preferred embodiment, the tubular member may include one or more protrusions or tabs, e.g., extending radially outwardly from the distal end of the tubular member. The closure element may include a plurality of pockets for receiving respective tabs on the tubular member therein, thereby coupling the closure element to the tubular member using the tabs. For example, the closure element may include a plurality of alternating diagonal elements extending between the proximal and distal ends of the closure element. The distal end of the closure element may include curved elements connecting adjacent diagonal elements, the curved elements defining the pockets.


Optionally, a skin may overlie at least a portion of the outer surface of the elongate member between the carrier assembly and the distal end of the elongate member, and may at least partially overlie the closure element. The skin may be separable from the outer surface as the closure element is advanced towards the distal end of the elongate member, similar to the previous embodiment.


During use, the distal end of the elongate member may be inserted into an opening through tissue, e.g., into a puncture communicating with a blood vessel, and a procedure may be performed, similar to the previous embodiment. Upon completing the procedure, a distal end of the actuator member may be inserted between the hub and the outer surface of the elongate member. Thus, the actuator member may pass under the spacers, and consequently, under the proximal end of the closure element, until the distal end of the actuator member is coupled with the closure element, e.g., received in pockets adjacent the distal end of the closure element. The actuator member may be advanced distally, thereby advancing the closure element towards the distal end of the elongate member. Tissue adjacent the distal end of the elongate member may be engaged with tissue engaging elements on the closure element, and the elongate member may be withdrawn from the opening, leaving the closure element to close and/or seal the opening. Alternatively, the closure element may be carried by the distal end of the actuator member, rather than being disposed initially adjacent the hub. In this alternative, the closure element may be introduced between the hub and the elongate member when the actuator member is connected to the hub, and advanced along the elongate member as the actuator member is advanced.


Other objects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an exploded side view of a first preferred embodiment of an apparatus for delivering a closure element, including an introducer sheath, an actuator assembly, and an obturator, in accordance with the present invention.



FIG. 2 is a cross-sectional side view of the apparatus of FIG. 1.



FIGS. 3A and 3B are cross-sectional views of alternative embodiments of the introducer sheath of FIG. 1.



FIG. 4 is a side view of the apparatus of FIG. 1, with the actuator assembly connected to the sheath, and an obturator inserted through the actuator assembly and sheath.



FIGS. 5A and 5B are perspective views of the distal end of the obturator of FIG. 4, showing positioning elements on the obturator in collapsed and expanded configurations, respectively.



FIGS. 6A-6G are cross-sectional views of a blood vessel, showing a method for delivering a clip into with a wall of the vessel.



FIG. 7 is a perspective view of a second preferred embodiment of an apparatus for delivering a closure element, including an introducer sheath, and an actuator assembly, in accordance with the present invention.



FIG. 8 is a perspective detail of the apparatus of FIG. 7 with the actuator assembly attached to the introducer sheath.



FIGS. 9A-9C are cross-sectional details of the apparatus of FIGS. 7 and 8.



FIG. 10 is a cross-sectional view of a blood vessel, showing a closure element being delivered by the apparatus of FIG. 7.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Turning now to the drawings, FIGS. 1, 2, and 4 show a first preferred embodiment of an apparatus 10 for delivering a closure element, such as a clip 5, into an opening through tissue for closing and/or sealing the opening (not shown). Generally, the apparatus 10 includes an introducer sheath 12, a housing or carrier assembly 14 slidably disposed on the sheath 12, and a skin 44 overlying the sheath 12 and/or carrier assembly 14. The apparatus 10 may also include an actuator or handle assembly 16 that is connectable to the sheath 12. Optionally, as shown in FIG. 4, the apparatus 10 may also include a locator member or obturator 18 that may be insertable through the actuator assembly 16 and/or sheath 12 for assisting positioning of the apparatus, as described further below.


The sheath 12 is generally a substantially flexible or semi-rigid tubular member including a lumen 20 extending along a longitudinal axis 28 between its proximal and distal ends 22, 24. The distal end 24 has a size and shape to facilitate insertion into an opening through tissue (not shown), e.g., having a tapered tip 26 for facilitating substantially atraumatic introduction through a passage and/or at least partially into a blood vessel or other body lumen accessed via the passage. The lumen 20 has a size for accommodating insertion of one or more devices therethrough, such as a catheter, guidewire, and the like (not shown). The sheath 12 may also include a seal (not shown), such as a hemostatic valve, within the lumen 20, e.g., at or near the proximal end 22, that may provide a fluid-tight seal, yet accommodate inserting one or more devices, such as the obturator 18, into the lumen 20 without fluid passing proximally from the sheath 12.


An annular hub 30 may be provided on the proximal end 22 of the sheath 12, e.g., attached by one or more radial spokes, such as the spoke 31 shown in FIG. 2. Preferably, the hub 30 and the sheath 12 define a “C” shaped passage 38 (or multiple passages if multiple spokes are provided) therebetween that extends substantially parallel to the longitudinal axis 28. In addition, the hub 30 may include one or more connectors on its proximal end 32, such as recesses or pockets 34, for cooperating with mating connectors 80 on the actuator assembly 16, as described further below. Alternatively, the actuator assembly 16 may be connectable directly to the proximal end 22 of the sheath 12 (not shown), may be provided as an integral component of the sheath 12 (not shown), or may otherwise extend from the proximal end 22 of the sheath 12, e.g., such that the hub 30 may be eliminated.


Optionally, the hub 30 may include a side port (not shown) that communicates with the lumen 20, for example, to allow infusion of fluids into the lumen 20 through the sheath 12. Alternatively, or in addition, the side port may be used to provide a “bleed back” indicator, such as that disclosed in co-pending application Ser. No. 09/680,837, filed Oct. 6, 2000, which is assigned to the assignee of the present invention. The disclosure of this application and any references cited therein are expressly incorporated herein by reference.


In a further alternative, the spokes 31 may be eliminated from the hub 30, and the hub 30 may be secured to the sheath 12 by an annular seal or other frictional member (not shown). When the actuator assembly 16 is attached to the sheath 12, as described further below, the hub 30 may at least partially break away or may be secured to the actuator assembly 16. The actuator assembly 16 and/or the obturator 18 may frictionally or mechanically become secured to the sheath 12 to prevent the apparatus 10 from separating during use.


The carrier assembly 14 is slidably disposed on an outer surface 13 of the sheath 12 and is configured for releasably holding the clip 5. The carrier assembly 14 is slidable from a proximal position, e.g., adjacent the hub 30, and preferably at least partially disposed within the passage 38, towards the distal end 24 of the sheath 12.


With particular reference to FIG. 2, the carrier assembly 14 may include an inner or carrier member 40 and an outer or pusher member 42 that are nested together and coaxially disposed around the sheath 12. The carrier member 40 is an annular-shaped body including proximal and distal ends 46, 48, and a ramped region 50 adjacent the distal end 48. The ramped region 50 may include a ramped proximal surface 50a, e.g., for facilitating deployment of the clip over the ramped region 50, and/or a ramped distal surface 50b, e.g., for facilitating advancement of the carrier assembly 14, as described further below. The distal end 48 of the carrier member 40 may be tapered, and/or, alternatively, the carrier member 40 may include a plurality of ramped regions (not shown) adjacent the distal end 48, rather than a single annular ramped region, e.g., spaced evenly about a perimeter or other periphery of the carrier member 40.


The carrier member 40 may include a connector (not shown) on the proximal end 46 for coupling the carrier member 40 to the actuator assembly 16. Alternatively, the carrier member 40 may be coupled to the hub 30 and/or to the proximal end 22 of the sheath 12 by a tether or other element (not shown) for limiting distal movement of the carrier member 40, as described further below.


The pusher member 42 may also be an annular body, including proximal and distal ends 56, 58 and may include a connector (not shown) on its proximal end 56 for coupling the pusher member 42 to the actuator assembly 16. The distal end 58 may be substantially blunt to engage the clip 5, e.g., to advance or deploy the clip 5 from the carrier assembly 14, as described further below. The pusher member 42 is configured to slidably fit around the carrier member 40, but has a substantially shorter length than the carrier member 40, such that the carrier and pusher members 40, 42 define a space 15 distal to the distal end 58 of the pusher member 42 and along an outer surface of the carrier member 40 for receiving the clip 5.


The carrier assembly 14 may be used to deploy a clip 5 or other closure element from the space 15 defined by the carrier assembly 14. In a preferred embodiment, the clip 5 is a generally annular-shaped body, including one or more tines 7 for engaging the tissue around an opening, e.g., adjacent to a wall of a blood vessel (not shown). Preferably, the clip 5 is configured for drawing the tissue around a puncture in the wall of a blood vessel substantially closed and/or sealed, e.g., for enhancing hemostasis within the puncture. Exemplary embodiments of a closure element for use with an apparatus in accordance with the present invention are disclosed in U.S. Pat. No. 6,197,042, and in co-pending application Ser. Nos. 09/546,998 and 09/610,238, the disclosures of which are expressly incorporated herein by reference.


The carrier assembly 14 may be actuated from the proximal end 22 of the sheath 12, preferably by the actuator assembly 16, as explained further below. The carrier assembly 14 may be substantially permanently but slidably disposed on the sheath 12. For example, the carrier assembly 14 may be initially stored at least partially within the passage 38 under the hub 30. Alternatively, the carrier assembly 14 may be provided separate from the sheath 12 (not shown), e.g., with the clip 5 pre-loaded therein, but may be slidably attached to the sheath 12 before deploying the clip 5.


The skin 44 overlies at least a portion of the outer surface 13 of the sheath 12 and the carrier assembly 14. Preferably, the skin 44 extends from the carrier assembly 14 towards the distal end 24 of the sheath 12, e.g., having a proximal end 66 that at least partially covers the clip and a distal end 68 proximate the distal end 24 of the sheath 12. The skin 44 may be substantially secured over the sheath 12, thereby substantially securing the skin 44 from moving axially relative to the sheath 12.


The skin 44 may be separable from the outer surface 13 of the sheath 12 as the carrier assembly 14 is advanced from its proximal position towards the distal end 24 of the sheath 12. For example, the distal end 68 of the skin 44 may terminate adjacent the distal position to which the carrier assembly 14 may be advanced such that the clip 5 may be disposed beyond the distal end 68 of the skin 44 in the distal position.


The skin 44 may be substantially inelastic, e.g., such that the skin 44 may tear when expanded, or alternatively may be elastic. In addition or alternatively, the skin 44 may include an outer surface 70 that is substantially slippery to facilitate advancing the sheath 12 through layers of tissue (not shown), as described further below. The skin 44 may be formed from a variety of materials, e.g., having sufficient flexibility to allow the carrier assembly 14 to be advanced between the skin 44 and the outer surface 13 of the sheath 12 and/or sufficient rigidity to allow the skin 44 to separate or peel away from the outer surface 13 in a predictable and desired manner. Exemplary materials from which the skin 44 may be formed include polytetrafluoroethylene (PTFE), polyethylene terephthalate (PET), polyester, latex, silicone, polyamides, polyurethanes, and/or blends and copolymers thereof. The skin 44 may have a thickness, for example, between about 0.002-0.005 inch. Optionally, the skin 44 may include fibers (not shown) embedded therein or on a surface thereof that may reinforce the skin 44 in a desired manner.


The skin 44 may be bonded to the outer surface 13 of the sheath 12, e.g., using an adhesive, such as an epoxy or urethane. Preferably, the adhesive has sufficient adhesive strength such that the skin 44 may not slide along the outer surface 13 of the sheath 12, yet may be peeled away from the outer surface 13, e.g., as the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12. Alternatively, the skin 44 may be thermally bonded to the outer surface 13, e.g., by heating the skin 44 and/or sheath 12 to at least partially melt or fuse the skin 44 to the outer surface 13.


Alternatively, the skin 44 may be a tube that is securely received around the outer surface 13. For example, the skin 44 may be a length of shrink tube, having an initial diameter that is substantially larger than the sheath 12. The shrink tube may be disposed around the sheath 12, heated, and, consequently, shrunk to wrap around or otherwise engage the outer surface 13 of the sheath 12, either with or without adhesive provided between the skin 44 and the outer surface 13.


Optionally, the skin 44 may include a weakened region 72 extending between the proximal and distal ends 66, 68 of the skin 44, as shown in FIG. 1. The weakened region 72 may be configured to tear or split preferentially as the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12. For example, the weakened region 72 may include a plurality of perforations spaced apart along the skin 44, thereby defining a seam extending between the proximal and distal ends 66, 68 of the skin 44. Alternatively, the weakened region 72 may include a relatively thin-walled seam or region (not shown) of the skin 44 in addition to or instead of the perforated seam.


In a further alternative, fibers (not shown) embedded in the skin 44 may bias the skin 44 to tear preferentially in a desired manner. For example, one or more fibers (not shown) may be may be bonded to the skin 44 that extend between the proximal and distal ends 66, 68 of the skin 44, thereby defining a seam adjacent or between the fibers that may tear preferentially. Alternatively, a plastic or other soft material may be bonded over a braided core (not shown) instead of or in addition to individual fibers, e.g., to create regions of the skin 44 that are resistant to tearing.


Although the weakened region 72 is shown extending substantially parallel to the longitudinal axis 28, the weakened region 72 may extend helically (not shown) or otherwise between the proximal and distal ends 66, 68. The term “axially” as used herein is intended to include any arrangement that may extend generally towards the proximal and/or distal ends 22, 24 of the sheath 12. When the carrier assembly 14 is advanced under the skin 44, the weakened region 72 may tear such that the skin 44 separates or peels away from the outer surface 13, as described further below.


Turning to FIG. 3A, in an alternative embodiment, the skin 44 may be a tubular sleeve 44′ that has a relaxed diameter or other periphery that is substantially larger than a diameter or other periphery of the sheath 12. The sleeve 44′ may be wrapped around the outer surface 13 of the sheath 12 until a portion of the sleeve 44′ is folded over itself to define a flap 45.′ The flap 45′ may then be laid over an adjacent region 47′ of the sleeve 44′, whereupon the flap 45′ may be bonded or otherwise fastened in order to secure the sleeve 44′ to the sheath 12. Thus, as the carrier assembly 14 (not shown in FIG. 3A) is advanced along the sheath 12, the adhesive may fail, and the flap 45′ may separate from the adjacent region 47′ of the sleeve 44′ as the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12.


Turning to FIG. 3B, in another alternative embodiment, the skin 44 may be a tubular sleeve 44″ that is slitted generally axially such that the sleeve 44″ defines first and second portions 45″, 47″ including edges. When the edges of the first and second portions 45″, 47″ abut one another, the sleeve 44″ defines a diameter or other periphery that is substantially larger than a diameter or other periphery of the sheath 12. The sleeve 44″ may be wrapped around the outer surface 13 of the sheath 12 until the first portion 45″ overlies the second portion 47.″ The first or outer portion 45″ may then be bonded or otherwise fastened to the second or inner portion 47″ in order to secure the sleeve 44″ to the sheath 12. Thus, as the carrier assembly 14 (not shown in FIG. 3B) is advanced along the sheath 12, the adhesive may fail, and the outer portion 45″ may separate from the adjacent region 47″ as the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12.


The sleeve 44″ may have a substantially uniform thickness about its circumference. Alternatively, the sleeve 44″ may have a variable thickness about the circumference. For example, the sleeve 44″ may have a relatively thin thickness in the first and second portions 45,″ 47,″ which may provide a more uniform overall cross-section for the skin 44, as shown in FIG. 3B.


Returning to FIG. 1, the actuator assembly 16 generally includes a handle body 74 and a plurality of telescoping actuator members 76, 78. The handle body 74 includes one or more connectors 80 for connecting the actuator assembly 16 to the sheath 12. For example, the handle body 74 may include a plurality of tabs 80 for engaging mating pockets 34 in the hub 30 or one or more pockets (not shown) for receiving respective tabs (not shown) on the hub 30 of the sheath 12. Thus, the actuator assembly 16 may be substantially permanently attached or removably attached to the sheath 12 by cooperating connectors 34, 80.


In the preferred embodiment shown, the telescoping actuator members 76, 78 include an inner tubular member 76 and an outer tubular member 78. The tubular members 76, 78 may be substantially rigid members having longitudinal slots therein (not shown), thereby defining generally “C” shaped cross-sections over at least a substantial portion of their lengths. Preferably, the longitudinal slots have a width greater than a width of the spoke(s) 31 securing the hub 30 to the sheath 12, thereby allowing the tubular members 76, 78 to slide distally beyond the hub 30, as described further below. The longitudinal slots may extend predetermined distances from ends of the respective tubular members 76, 78, e.g., to limit movement of the tubular members 76, 78 in a desired manner, or may extend the entire length of one or both tubular members 76, 78. Alternatively, the longitudinal slots may be eliminated from the actuator members, such that the actuator members are enclosed wall tubes, if the spokes are eliminated from the hub 30 (not shown).


The distal ends 82, 84 of the tubular members 76, 78 may include detents (not shown) for engaging respective detents on the carrier assembly 14. For example, the detents may be pockets for receiving respective tabs (also not shown) on the carrier and pusher members 40, 42. Thus, movement of the carrier and/or pusher members 40, 42 may be coupled to the inner and outer tubular members 76, 78, respectively. Alternatively, the distal ends 82, 84 of the tubular members 76, 78 may simply abut the carrier and pusher members 40, 42 for pushing the carrier and pusher members 40, 42, thereby coupling distal movement of the carrier and pusher members 40, 42 to the tubular members 76, 78.


In an alternative embodiment, the tubular members 76, 78 may be replaced with one or more elongate rods, bands, or other actuator elements (not shown) that may extend from the handle body 74 and may engage, abut, or otherwise be coupled to the carrier assembly 14. Preferably, the actuator elements are substantially rigid such that they do not buckle when directed distally against the carrier assembly 14. In addition, the actuator elements may be substantially flat such that they slide along the outer surface 13 of the sheath 12, thereby facilitating insertion between the hub 30 and the sheath 12 and/or minimizing a cross-sectional profile.


The actuator assembly 16 also includes a control member, such as a shaft 86, that is coupled to the inner and/or outer tubular members 76, 78. Preferably, the shaft 86 is connected only to the outer tubular member 78, while the inner tubular member 76 is releasably coupled to the outer tubular member 78, as explained further below. Thus, axial movement of one or both of the tubular members 76, 78 may be attained by applying an axial force to the shaft 86.


Optionally, the actuator assembly 16 may also include other components. For example, a lateral port 88 may include an inner passage 89 that communicates with an interior region or lumen (not shown) of the telescoped tubular members 76, 78. Preferably, the lateral port 88 extends through the slots in the tubular members 76, 78, although alternatively, separate slots (not shown) may be provided for the lateral port 88. The lateral port 88 may include one or more detents (not shown) for securing the obturator 18 or other device within the lateral port 88, as described below. In addition, the actuator assembly 16 may include a trigger (not shown) for releasing the obturator 18, as described further below.


Turning to FIGS. 4, 5A, and 5B, the obturator 18 includes a flexible or semi-rigid tubular body or other elongate rail 172 having proximal and distal ends 174, 176. An actuator rod, wire, or other elongate member 178 is slidably disposed with respect to the rail 172, e.g., within a lumen of the rail 172. Preferably, the obturator 18 includes an obturator housing 180 on the proximal end 174. The obturator housing 180 and/or the proximal end 174 of the rail 172 may include one or more detents (not shown) for engaging complementary-shaped detents (also not shown) on the lateral port 88 of the actuator assembly 16. Thus, the obturator 18 may be substantially secured axially with respect to the lateral port 88.


With particular reference to FIGS. 5A and 5B, a distal portion 182 of the obturator 18 may include a substantially rounded, soft, and/or flexible distal tip 184, possibly including a pigtail (not shown) that may facilitate atraumatic advancement of the distal portion 182 into a blood vessel or other body lumen (not shown). The obturator 18 preferably has a length relative to the sheath 12 such that the distal portion 182 may extend beyond the distal end 24 of the sheath 12 when the obturator 18 is fully received in the actuator assembly 16 and sheath 12, as shown in FIG. 4.


One or more, and preferably a plurality of, positioning elements 186 are provided on the distal portion 182 that may be selectively expanded between a substantially axial collapsed configuration (shown in FIG. 5A) and a substantially transverse expanded configuration (shown in FIG. 5B). Preferably, the positioning elements 186 are substantially flexible splines configured for expanding substantially transversely with respect to the longitudinal axis 28. In one embodiment, shown in FIGS. 5A and 5B, the obturator 18 includes a pair of splines 186 disposed generally opposite one another about the distal portion 182. Alternatively, the obturator 18 may include four or any other number of splines (not shown) that are substantially equally spaced about the distal portion 182. Additional information on positioning elements that may be used are disclosed in co-pending application Ser. No. 09/732,835, the disclosure of which is expressly incorporated herein by reference.


Optionally, the splines 186 may include radiopaque markers (not shown) or may be at least partially formed from radiopaque material to facilitate observation of the splines 186 using fluoroscopy or other imaging systems. Alternatively, or in addition, the carrier assembly 14 may include one or more radiopaque markers, e.g., at its distal end (not shown) and/or the clip 5 may include radiopaque marker(s) or may be made from radiopaque material. This may facilitate monitoring the location of the clip 5 relative to the splines 186, as described further below.


Turning to FIGS. 6A-6G, the apparatus 10 may be used to provide access into a blood vessel or other body lumen 90. Preferably, the apparatus 10 is used to deliver a closure device, such as the clip 5, to close and/or seal an incision, puncture, or other opening, such as a passage 92 that extends from a patient's skin 94 through intervening tissue 96, and a wall 98 of the vessel 90. Alternatively, the apparatus 10 may be used to deliver other annular shaped devices (not shown) that may be carried by the carrier assembly 14.


As shown in FIG. 6A, the sheath 12, without the actuator assembly 16 attached and without the obturator 18 therein (both not shown), may be inserted or otherwise positioned within the blood vessel 90, i.e., through the passage 92. The sheath 12 is preferably provided with the carrier assembly 14 in its proximal position, e.g., adjacent to or within the hub 30. The skin 44 may facilitate advancing the sheath 12 through the passage 92, e.g., by providing a slippery outer coating on the skin 44, e.g., of PTFE. In particular, the skin 44 may facilitate advancing the sheath 12 through one or more intervening layers of tissue, such as layers of fascia 97, which may otherwise catch on the sheath 12.


The sheath 12 may be advanced over a guide wire or other rail (not shown) previously positioned through the passage 92 into the blood vessel 90 using conventional procedures. Preferably, the blood vessel 90 is a peripheral vessel, such as a femoral or carotid artery, although other body lumens may be accessed using the sheath 12, as will be appreciated by those skilled in the art. The passage 92, and consequently the sheath 12, may be oriented with respect to the vessel 90, thereby facilitating introducing devices through the lumen 20 of the sheath 12 into the vessel 90 with minimal risk of damage to the vessel 90. One or more devices, such as a guide wire, catheter, and the like (not shown), may be inserted through the sheath 12 and advanced to a desired location within the patient's body. For example, the devices may be used to perform a therapeutic or diagnostic procedure, such as angioplasty, atherectomy, stent implantation, and the like, within the patient's vasculature.


After completing the procedure, any device(s) may be removed from the sheath 12, and the actuator assembly 16 may be attached to the hub 30 of the sheath 12, as shown in FIG. 6B. The tabs 80 on the actuator assembly 16 may be inserted into the pockets 34 on the hub 30 of the sheath 12 (not shown in FIG. 6B), which may align the tubular members 76, 78 such that the distal ends 82, 84 may be inserted freely into the passage 38. If the carrier assembly 14 includes detents (not shown) for being engaged with the distal ends 82, 84 of the tubular member 76, 78, the detents may become engaged as the tabs 80 are inserted into the pockets 34. Alternatively, the tubular members 76, 78 may be advanced into the passage 38 by pushing on the shaft 86 to secure the carrier assembly 14 to the tubular members 76, 78. In a further alternative, the distal ends 82, 84 may simply abut the carrier assembly 14.


Turning to FIG. 6C, the obturator 18 may then be inserted into the lateral port 88, through the interior of the tubular members 76, 78 and into the lumen 20 of the sheath 12. When the obturator 18 is fully inserted within the sheath 12, the actuator housing 180 may be received in the lateral port 88, and the distal portion 182 of the obturator 18 may extend beyond the distal end 24 of the sheath 12. The distal tip 184 preferably is substantially soft and/or flexible such that the distal portion 182 substantially atraumatically enters the vessel 90. In this fully inserted position, cooperating detents (not shown), e.g., on the actuator housing 180 and the lateral port 88, may be engaged to secure the obturator 18 axially within the actuator assembly 16. Alternatively, the obturator 18 may be pre-attached to the actuator assembly 16, e.g., as a single assembly, as described in co-pending application Ser. No. 10/081,723, filed on the same day as the present application and titled “Apparatus and Methods for Delivering a Closure Element”. The disclosure of this application and any references cited therein are expressly incorporated herein by reference.


As shown in FIG. 6D, the splines 186 may then be directed to their expanded configuration, for example, by activating a switch (not shown) on the obturator housing 180 of the obturator 18. The sheath 12 and obturator 18 may then be moved in conjunction with one another, e.g., by manipulating the actuator assembly 16. Preferably, the sheath 12 and obturator 18 are together partially withdrawn from the vessel 90, until the splines 186 contact the wall 98 of the vessel 90. Thus, the splines 186 may provide a tactile indication of the position of the sheath 12 with respect to the wall 98 of the vessel 90. In addition, the splines 186 may assist in “presenting” the wall 98 of the vessel 90, e.g., for receiving the clip 5 (or other closure element) if the clip 5 is to engage the wall 98.


Alternatively, one or more bleed back ports (not shown) may be used to position the sheath 12, either instead of or in addition to the obturator 18. Such methods are described in U.S. Pat. No. 6,197,042, issued Mar. 6, 2001 or in co-pending application Ser. No. 09/680,837, filed Oct. 6, 2000. The disclosures of these references and any others cited therein are expressly incorporated herein by reference.


Turning to FIG. 6E, with the sheath 12 properly positioned, the carrier assembly 14 may be advanced along the sheath 12, i.e., into the passage 92 to deliver the clip 5. For example, a distal force may be applied to the shaft 86, thereby advancing the tubular members 76-80 distally over the sheath 12. Because the tubular members 76, 78 are coupled to the carrier assembly 14, the carrier assembly 14 advances along the outer surface 13 of the sheath 12 as the tubular members 76, 78 are pushed distally.


As the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12, the carrier assembly 14 may cause the skin 44 to separate from the outer surface 13 of the sheath 12. Preferably, the distal end 48 of the carrier member 40 includes a ramped region 50 including a ramped distal surface 50b (not shown, see FIG. 2). The ramped distal surface 50b may slidably engage the skin 44, peeling the skin 44 from the outer surface 13 of the sheath 12 and directing the skin 44 outwardly away from the tines 7 of the clip 5. Thus, the ramped region 50 may ensure that the tines 7 of the clip 5 do not engage the skin 44 and possibly entangle or tear the skin 44 in an undesired manner.


If, as shown in FIG. 1, the skin 44 includes a weakened region 72, the weakened region 72 may tear as the carrier assembly 14 is advanced and the skin 44 is forced to expand due to the increased size of the ramped region 50. Alternatively, if the skin 44 is formed from an elastic material, the skin 44 may simply expand and separate from the outer surface 13 to accommodate the carrier assembly 14 passing under the skin 44. In a further alternative, as shown in FIGS. 3A and 3B, the skin 44 may include a flap 45′ or outer portion 45″ overlying an adjacent region 47′, 47″ of the skin 44. The flap 45′ or outer portion 45″ may be released from the adjacent region 47′, 47″ as the carrier assembly 14 is advanced towards the distal end of the elongate member, thereby allowing the skin 44 to separate from the outer surface 13. If the skin is bonded to the outer surface 13 of the sheath 12 by an adhesive, the adhesive may allow the skin 44 to be peeled away from the outer surface 13 as the carrier assembly 14 is advanced towards the distal end 24 of the sheath 12.


Because the carrier assembly 14 passes beneath the skin 44, i.e., between the skin 44 and the outer surface 13 of the sheath 12, as it advances along the sheath 12, the skin 44 may facilitate advancing the carrier assembly 14 through one or more intervening layers of fascia 97 or other tissue. Thus, the distal end 48 of the carrier member 40 may not directly contact the layers of fascia 97, thereby minimizing the risk of the carrier assembly 14 and/or the clip 5 catching or otherwise being held up by the intervening layers of fascia 97.


In addition, the tapered configuration of the ramped region 50 may facilitate advancing the carrier assembly through the passage 92 substantially atraumatically. Further, because the clip 5 is substantially covered by the skin 44, the tissue surrounding the passage 92 may not be exposed to the tines 7 on the clip 5, which otherwise may inadvertently catch the tissue and damage the tissue and/or the clip 5.


As shown in FIG. 6F, when the carrier assembly 14 reaches a distal position, the clip 5 may become at least partially exposed beyond the distal end 68 of the skin 44. In addition, the inner tubular member 76 may become locked from further distal movement, consequently preventing further distal movement of the carrier member 40 of the carrier assembly 14. Thus, subsequent distal force on the shaft 86 may cause the pusher member 42 to advance distally relative to the carrier member40, thereby deploying the clip 5 from the carrier member 40. In a preferred embodiment, the ramped region 50 includes a ramped proximal surface 50a that may deflect the tines 7 and/or the entire clip 5 radially outwardly. Thus, the ramped region 50 may direct the tines 7 outwardly into surrounding tissue and/or may advance the clip 5 over the ramped region 50 and into tissue beyond the distal end 24 of the sheath 12.


In an alternative embodiment, the skin 44 may cover the clip 5 in the distal position. As the pusher member 42 is advanced distally, the clip 5 may be directed over the ramped region 50, thereby causing the tine 7 to tear through the skin 44 and into surrounding tissue.


To lock the carrier member 40 in the distal position, the inner tubular member 76 may include detents (not shown) that engage with a region of the hub 30 and/or sheath 12 to prevent further distal movement. Alternatively, a tether (also not shown) may be coupled to the carrier member 76 that may prevent further distal movement of the carrier member 76 beyond the distal position.


Returning to FIG. 6F, the splines 186 on the obturator 18 may be collapsed before, during, or after deploying the clip 5 from the carrier assembly 14. Preferably, the splines 186 automatically return to their collapsed configuration before the clip 5 is ejected completely from off of the carrier member 40. For example, a trigger (not shown) in the actuator assembly 16 may release a locking mechanism (also not shown) in the actuator housing 180, whereupon the actuator housing 180 may be biased to collapse the splines 186. In addition, the obturator 18 may include a spring or other biasing mechanism to automatically withdraw the distal portion 182 into the sheath 12 once the splines 186 are collapsed. This feature may avoid any risk of contact between the clip 5 and the splines 186, e.g., which otherwise may risk driving the tines 7 of the clip 5 through the wall 98 of the vessel 90 and into the splines 186. Alternatively, the tines 7 on the clip 5 may be aligned to extend between the splines 186, thereby avoiding any contact between the tines 7 and the splines 186, and the splines 186 may be collapsed after the clip 5 is at least partially deployed.


The relative lengths of the tubular members 76, 78 and the sheath 12 may be selected such that the distal position is at a region proximal to the wall 98 of the vessel 90. For example, it may be desirable to deploy the clip 5 within intervening tissue between the patient's skin and the wall 98 of the vessel 90. Alternatively, the clip 5 may be deployed such that the tines 7 are driven into or through the wall 98 of the vessel 90, as shown in FIGS. 6F and 6G.


Once the clip 5 is successfully delivered, the apparatus 10 may be withdrawn from the passage 92, leaving the clip 5 to close the opening in the wall 98 or otherwise seal the passage 92, as shown in FIG. 6G. If the splines 64 of the locator member 14 are not automatically collapsed while advancing the housing 24, the splines 64 may be affirmatively collapsed, e.g., by depressing a switch (not shown) on the actuator housing 180, either before or after deployment of the clip 5. The entire apparatus 10 may then be removed in one step, or alternatively, the obturator 18 may first be withdrawn from the sheath 12 before withdrawing the sheath 12, thereby leaving the clip 5 in place to close and/or seal the passage 92. In an alternative embodiment, the distal tip 184 of the obturator 18 may be formed from a bioabsorbable and/or expandable material, e.g., collagen, and may be detachable such that the distal tip 184 may be released within the passage 92 to enhance sealing.


Turning to FIGS. 7-9, another embodiment of an apparatus 210 is shown for delivering a closure element, such as a clip 205, into an opening through tissue (not shown) for closing and/or sealing the opening. Generally, the apparatus 210 includes an introducer sheath 212, a plunger or actuator assembly 216 that may be coupled to the sheath 212 and/or clip 205, and a skin 244 overlying an outer surface 213 of the sheath 212 and/or the clip 205. Optionally, the apparatus 210 may also include a locator member or obturator 218 (not shown, see FIG. 10) that may be insertable through the actuator assembly 216 and/or sheath 212 for assisting positioning of the apparatus, similar to the embodiment described above.


The sheath 212 is generally a substantially flexible or semi-rigid tubular member including a lumen 220 extending along a longitudinal axis 228 between its proximal and distal ends 222, 224. The distal end 224 has a size and shape to facilitate insertion into an opening through tissue (not shown), e.g., having a tapered tip 226 for facilitating substantially atraumatic introduction through a passage and/or at least partially into a blood vessel or other body lumen accessed via the passage. The lumen 220 has a size for accommodating inserting one or more devices therethrough, such as the obturator 218, a catheter, a guidewire, and the like (not shown). The sheath 212 may also include a seal (not shown) that may provide a fluid-tight seal, yet accommodate inserting one or more devices into the lumen 20, similar to the embodiment described above.


An annular hub 230 is provided on the proximal end 222 of the sheath 212, e.g., attached by one or more radial spokes 231. Preferably, the hub 230 and the sheath 212 define an annular or “C” shaped passage 238 between the outer surface 213 of the sheath 212 and an inner surface 237 of the hub 230 that extends substantially parallel to the longitudinal axis 228. The actuator assembly 216 may be slidably coupled to the hub 230, e.g., by inserting the distal end of the actuator assembly 216 into the passage 238. Alternatively, the hub 230 may include one or more connectors (not shown) on its proximal end 232 for cooperating with mating connectors (also not shown) on a housing (also not shown) of the actuator assembly 216, similar to the embodiment described above. Optionally, the hub 230 may include a side port (not shown) that communicates with the lumen 220, for example, to allow infusion of fluids into the lumen 220 through the sheath 212 and/or to provide a “bleed back” indicator, as described above.


The hub 230 includes a plurality of spacers or alignment tabs 234 extending from a distal end 233 of the hub 230. Preferably, the tabs 234 are spaced apart from the outer surface 213 of the sheath 212 and extend substantially parallel to the longitudinal axis 228. For example, as best seen in FIGS. 9A-9C, an inner surface 234a of the tabs 234 may be aligned with the inner surface 237 of the hub 230 such that the tabs 234 do not obstruct the passage 238. In a preferred embodiment, the tabs 234 are spaced evenly about the circumference of the hub 230, e.g., in a desired orientation relative to the passage 238, as explained further below. Alternatively, an annular ridge (not shown) may be provided that extends continuously around the circumference of the hub 230, thereby defining a single, continuous spacer.


The clip 205, best seen in FIG. 8, is an annular-shaped member including proximal and distal ends 206, 208 and a plurality of tissue engaging elements 207 extending from the distal end 208. In a preferred embodiment, the clip 205 includes a plurality of alternating diagonal elements 209 extending between the proximal and distal ends 206, 208. The proximal and distal ends 206, 208 of the clip 205 include curved elements connecting adjacent diagonal elements 209, the curved elements alternating between the proximal and distal ends 206, 208 around the circumference of the clip 205 such that the clip 205 defines a substantially continuous serpentine or zigzag pattern about the circumference. Alternatively, the clip may include one or more loops (not shown) between adjacent tissue engaging elements, which may enhance a flexibility of the clip 205. Additional information on such a clip may be found in co-pending application Ser. No. 10/081,726, filed on the same day as the present application, and titled “Closure Apparatus and Methods for Making and Using Them”. The disclosure of this application and any references cited therein are expressly incorporated herein by reference.


Preferably, the tissue engaging elements are tines 207 extending distally from the distal end 208. Optionally, the tines 207 or the distal end 208 may include offset elements 204, e.g., on an inner surface thereof for maintaining the tines 207 away from the outer surface 213 of the sheath, as best seen in FIGS. 9A-9C. The offset elements 204 may simply be rounded tabs formed on an inner surface of the clip 205, e.g., having a thickness greater than the rest of the clip 205 or may be separate elements attached to the clip 205.


In a preferred embodiment, the tines 207 are biased towards one another, e.g., for engaging tissue surrounding an opening and drawing the tissue inwardly to substantially close and/or seal the opening. For example, the distal curved elements 208 of the clip 205 may be biased to move inwardly and/or the proximal curved elements 206 may be biased to move outwardly. Thus, in a preferred embodiment, the clip 205 is biased towards a planar configuration with the tines 207 directed inwardly towards one another (not shown). Additional information on clips appropriate for use with the apparatus 210 may be found in application Ser. Nos. 09/546,998 and 09/610,238, incorporated by reference above.


Returning to FIG. 8, the clip 205 is initially carried adjacent the proximal end 222 of the sheath 212 such that the proximal end 206 of the clip 205 overlies or engages the tabs 234 on the hub 230, thereby retaining the proximal end 206 of the clip 205 away from the outer surface 213 of the sheath 212 and in a desired orientation. The spacing of the tabs 234 on the hub 230 may correspond to the spacing of the proximal curved elements 206 of the clip 205, e.g., such that each proximal curved element 206 is held away from the outer surface 213 of the sheath 212 by a respective tab 234. Preferably, the tabs 234 hold the clip 205 in the desired orientation to ensure that the clip 205 is properly coupled to the actuator assembly 216, as described further below. In this initial position, the distal end 208 of the clip 205 may rest against the outer surface 213 of the sheath 212, although the tines 207 may be retained away from the outer surface 213 by the offset elements 204.


The skin 244 may overlie at least a portion of the outer surface 213 of the sheath 212 and the clip 205. Preferably, the skin 44 extends from the clip 205 towards the distal end 24 of the sheath 12, e.g., having a proximal end 266 that at least partially covers the clip 205 and a distal end 268 proximate the distal end 224 of the sheath 212. The skin 244 may be substantially secured over the sheath 212, thereby substantially securing the skin 244 from moving axially relative to the sheath 212, e.g., by friction and/or by an adhesive, similar to the embodiments described above. In a further alternative, the skin 244 may be eliminated from any of the embodiments described herein.


The skin 244 may be separable from the outer surface 213 of the sheath 212 as the clip 205 is advanced from its proximal position towards the distal end 224 of the sheath 212. The skin 244 may be formed from substantially inelastic materials, e.g., such that the skin 244 may tear when expanded, or alternatively from elastic materials, similar to the embodiments described above. Optionally, the skin 244 may include a weakened region (not shown) extending between the proximal and distal ends 266, 268 of the skin 244, and/or may include fibers (not shown) embedded in the skin 244 may bias the skin 244 to tear preferentially in a desired manner, as explained above.


The actuator assembly 216 generally includes a substantially rigid tubular member 276 including proximal and distal ends 281, 282. In a preferred embodiment, the tubular member 276 includes a slot 284 (not shown, see FIG. 7) extending at least partially between the proximal and distal ends 281, 282. The tubular member 276 has a “C” shaped cross-section defining a diameter corresponding generally to the outer surface 213 of the sheath 212 and has a thickness such that the distal end 282 may be slidably inserted into the passage 238 between the hub 230 and the sheath 212, as explained further below. The slot 284 may have a width corresponding to the spoke 231, thereby allowing the tubular member 276 to be directed distally through the passage 238 without substantial interference by the spoke 231. Alternatively, the actuator assembly 216 may include a plurality of substantially rigid bands separated by slots (not shown) that generally define a tubular structure or otherwise conform generally to the shape of the outer surface 213 of the sheath 212.


Optionally, the actuator assembly 216 may include a housing (not shown) that may be connected to the hub 230 and/or directly to the proximal end 220 of the sheath 212. The housing may secure the actuator assembly 216 to the sheath 212, may limit movement of the tubular member 276, and/or may contain internal components (not shown) of the actuator assembly 216, similar to the embodiment described above. In addition, a housing may ensure that the actuator assembly 216 is coupled to the sheath 212 in a desired orientation, e.g., to align the slot 284 of the tubular member 276 with the spoke 231 securing the hub 230 to the sheath 212, as explained further below.


The tubular member 276 includes a plurality of protrusions 288 on the distal end 282 for coupling distal movement of the clip 205 to the tubular member 276. Preferably, the protrusions 288 are tabs that extend radially outwardly from the distal end 282 of the tubular member 276. The protrusions 288 may be spaced apart about the circumference of the tubular member 276, preferably in a predetermined relationship to the tabs 234 extending from the hub 230 of the sheath 212. Preferably, the protrusions 288 are disposed between adjacent tabs 234 such that a protrusion 288 may be aligned with each distal curved element 208 of the clip 205 when the proximal curved elements 206 are engaged over the tabs 234. Thus, the distal curved elements 208 of the clip 205 may provide for pockets for receiving the protrusions 288 to couple the clip 205 to the tubular member 276.


During assembly of the apparatus 210, the distal end 282 of the tubular member 276 may be aligned with the passage 238 of the sheath 212, as shown in FIG. 7. The distal end 282 may be inserted into the passage 238, as shown in FIG. 9A, until the protrusions 288 pass between the tabs 234, and, consequently, between the proximal curved elements 206 of the clip 205. Thus, as the tubular member 276 is advanced distally, the protrusions 288 enter the pockets defined by the distal curved elements 208 and engage the distal curved elements 208 of the clip 205, as shown in FIG. 9B. With the clip 205 coupled to the tubular member 276, further distal movement of the tubular member 276 causes the clip 205 to move distally, as shown in FIG. 9C. As this occurs, the proximal curved elements leave the tabs 234 and travel along the outer surface 213 of the sheath 212.


If the apparatus 210 includes a skin 244 overlying the outer surface 213 of the sheath 212, the skin 244 may be separated from the outer surface 213 as the clip 205 is advanced towards the distal end 224 of the sheath 212, similar to the embodiment described above. In one embodiment, the protrusions 288 may have a height that is greater than a thickness of the clip 205 such that the protrusions 288 extend radially outwardly from the outer surface 213 of the sheath 212 a greater distance than the clip 205. Thus, the protrusions 288 may cause the skin 244 to separate from the outer surface 213, thereby minimizing the risk of the tines 207 of the clip 205 catching on the skin 244. Alternatively, the tines 206 may be oriented to prevent them from catching on the skin 244 or the skin 244 may include an interior surface that is substantially slippery such that the tines 207 may slide along the skin 244.


The apparatus 210 may be used to deliver the clip 205 or other closure element, similar to the embodiment described above. Initially, the sheath 212, without the actuator assembly 216, may be inserted or otherwise positioned within a blood vessel through a puncture or other passage. The sheath 212 is provided with the clip 205 in its proximal position, e.g., with the proximal end 206 held by the tabs 234 extending from the hub 230. The sheath 212 may be advanced over a guide wire or other rail (not shown) previously positioned through the passage into the blood vessel using conventional procedures. In a preferred method, the blood vessel is a peripheral vessel, such as a femoral or carotid artery, although other body lumens may be accessed using the sheath 212, as will be appreciated by those skilled in the art.


One or more devices, such as a guide wire, catheter, and the like (not shown), may be inserted through the sheath 212 and advanced to a desired location within the patient's body. For example, the devices may be used to perform a therapeutic or diagnostic procedure, such as angioplasty, atherectomy, stent implantation, and the like, within the patient's vasculature. After completing the procedure, any device(s) may be removed from the sheath 212, and the actuator assembly 216 may be inserted into the passage 238, as shown in FIGS. 9A and 9B, and as described above. If the actuator assembly 216 includes a housing (not shown), the housing may be attached to the hub 230 and/or to the sheath 212.


Alternatively, the clip 205 may be pre-loaded on the actuator assembly 216, rather than on the sheath 212. For example, the clip 205 may be disposed on the distal end 282 such that the protrusions 288 are disposed between the diagonal elements 209 and/or the distal curved elements 208. In this alternative, the spacers 234 on the hub 230 may be eliminated. Thus, the clip 205 may be advanced through the passage 238 as the actuator assembly 216 is coupled to the sheath 212. In a further alternative, a pusher member (not shown) may be disposed around the actuator assembly 216 for deploying the clip 205 from the actuator assembly 216.


As shown in FIG. 10, an obturator 218, similar to the obturator 18 described above, may then be inserted into the lumen 220 of the sheath 212, e.g., through a lateral port (not shown) communicating with the actuator assembly 216 or the hub 230. The distal tip 294 preferably is substantially soft and/or flexible such that the distal portion 292 substantially atraumatically enters the vessel. The obturator 218 may include a plurality of splines 296 on the distal portion 292 that are expandable from an axial collapsed configuration to a transverse expanded configuration, such as that shown in FIG. 10. In a preferred embodiment, the splines 296 are formed from substantially rigid segments, e.g., from stainless steel, connected by hinged regions such that the splines 296 may bend to the expanded configuration. When the obturator 218 is fully inserted into the sheath 212, the distal portion 292 extends beyond the distal end 224 of the sheath 212. Cooperating detents (not shown), e.g., on the obturator 218 and the lateral port, may be engaged to secure the obturator 218 with respect to the sheath 212.


With the obturator 218 inserted into the sheath 212, the splines 296 may be directed to their expanded configuration, for example, by activating a switch (not shown) on the proximal end of the obturator 218. The sheath 212 and obturator 218 may then be moved in conjunction with one another and preferably are together partially withdrawn from the vessel 96, until the splines 296 contact the wall 98 of the vessel 90. Thus, the splines 296 may provide a tactile indication of the position of the sheath 12 with respect to the wall 98 of the vessel 90. In addition, the splines 296 may assist in “presenting” the wall 98 of the vessel 90, e.g., for receiving the clip 205 (or other closure element) if the clip 205 is to engage the wall 98. Alternatively, one or more bleed back ports (not shown) may be used to position the sheath 212, either instead of or in addition to the obturator 18.


With the sheath 212 properly positioned, the clip 205 may be advanced along the sheath 212, i.e., into the passage 92, as described above. A distal force may be applied to the tubular member 276, thereby advancing the clip 205 distally over the sheath 212. As the clip 205 is advanced towards the distal end 224 of the sheath 212, the protrusions 288 and/or the clip 205 may cause the skin 244 to separate from the outer surface 213 of the sheath 212. Because the clip 205 passes beneath the skin 244, i.e., between the skin 244 and the outer surface 213, as it advances along the sheath 212, the skin 244 may facilitate advancing the clip 205 through one or more intervening layers, e.g., of fascia (not shown), similar to the embodiment described above.


As shown in FIG. 10, when the clip 205 reaches the distal end 224 of the sheath 212, the clip 205 may become at least partially exposed beyond the distal end 268 of the skin 244. Preferably, the clip 205 is entirely exposed beyond the distal end 268 of the skin 244 and the tines 207 are driven into or otherwise engage tissue adjacent the distal end 224 of the sheath 212. When the clip 205 is exposed, the clip 205 may begin to move towards a planar configuration, as shown in FIG. 10, such the proximal curved elements 206 move away from the distal end 282 of the tubular member 276. The splines 296 on the obturator 218 may be collapsed before, during, or after deploying the clip 205, and the apparatus 210 may be withdrawn from the passage 92. The clip 205 may then return to a substantially planar configuration, thereby closing and/or sealing the passage 92, similar to the embodiment shown in FIG. 6G.


While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the appended claims.

Claims
  • 1. A method for delivering a closure element to seal an opening through tissue beneath a patient's skin, the closure element being carried by a carrier assembly slidable on an outer surface of an elongate member, the elongate member comprising a sleeve member overlying at least a portion of the outer surface between the carrier assembly and a distal end of the elongate member and at least partially overlying the carrier assembly, the elongate member being provided with a locator member slidably associated therewith, said locator member having one or more expandable positioning elements on its distal portion, the method comprising: inserting the distal end of the elongate member through the patient's skin and into an opening through tissue;advancing the locator member distally from the distal end of the elongate member;expanding said one or more positioning elements;withdrawing said locator member until said positioning elements contact tissue;following locating said positioning elements in contact with the tissue, advancing the carrier assembly carrying the closure element towards the distal end of the elongate member from a location distal the patient's skin and distal the opening through tissue, the carrier assembly separating the sleeve member from the outer surface of the elongate member from a proximal end of the sleeve member toward a distal end of the sleeve member as the carrier assembly is advanced towards the distal end; anddeploying the closure element from the carrier assembly within the opening to substantially seal said opening, the closure element including one or more tines engaging the tissue and remaining within the tissue.
  • 2. The method of claim 1, further comprising removing the elongate member from the opening.
  • 3. The method of claim 1, wherein the sleeve member comprises a weakened region extending towards the distal end of the elongate member, the weakened region extending towards the distal end of the elongate member, the weakened region tearing as the carrier assembly is advanced towards the distal end of the elongate member.
  • 4. The method of claim 1, wherein the sleeve member expands to a cross-section that is larger than a cross-section of the elongate member as the carrier assembly is advanced towards the distal end.
  • 5. The method of claim 1, wherein the sleeve member is bonded to the outer surface of the elongate member by an adhesive, and wherein the adhesive has sufficient adhesive strength such that the sleeve member is peeled away from the outer surface as the carrier assembly is advanced towards the distal end.
  • 6. The method of claim 1, wherein the sleeve member comprises an outer surface that is substantially slippery for facilitating advancement of the elongate member into the opening through tissue.
  • 7. The method of claim 6, wherein the opening through tissue extends through one or more layers of fascia, and wherein the sleeve member facilitates advancement of the carrier assembly through the one or more layers of fascia.
  • 8. The method of claim 1, wherein the opening through tissue communicates with a blood vessel, and wherein the deploying step comprises substantially sealing the opening from blood flow therethrough with the closure element.
  • 9. The method of claim 1, further comprising coupling the carrier assembly to a proximal end of the elongate member.
  • 10. The method of claim 1, wherein the sleeve member comprises a plurality of longitudinal slots, the slots opening as the carrier assembly is advanced, thereby expanding the sleeve member.
  • 11. The method of claim 10, wherein the longitudinal slots are staggered relative to one another such that the sleeve member assumes a zigzag mesh configuration as it expands.
  • 12. The method of claim 1, further comprising contracting said positioning elements and withdrawing said locator member.
  • 13. The method of claim 1, wherein the distal end of the elongate member is inserted into the lumen of a blood vessel and wherein the positioning elements of the locator member are expanded within the lumen of a blood vessel.
  • 14. The method of claim 13, wherein the step of withdrawing the locator member causes the positioning elements to come into contact with the wall of the blood vessel.
  • 15. A method for delivering a closure element to seal an opening through tissue beneath a patient's skin, the closure element being carried by a carrier assembly slidable on the outer surface of an elongate member, the elongate member being at least partially located within a sleeve member having a proximal end disposed proximate the carrier assembly and a distal end disposed proximate the distal end of the elongate member, the method comprising: inserting a distal end of the elongate member, having a sleeve member located about the elongate member, through the patient's skin and into an opening through tissue which opening is in blood flow communication with a lumen of a blood vessel;following locating one or more positioning elements of a locator member in contact with the tissue and locating said distal end of the elongate member, advancing the carrier assembly carrying the closure element towards the distal end of the elongate member from a location distal the patient's skin and distal the opening through tissue, the advancement of the carrier assembly causing the sleeve member to be disrupted from the proximal end of the sleeve member toward the distal end of the sleeve member to permit such advancement; anddeploying the closure element from the carrier assembly to substantially seal said opening, the closure element including one or more tines engaging the tissue and remaining within the tissue.
  • 16. The method of claim 15, wherein said blood vessel is the femoral artery.
  • 17. The method of claim 15, wherein the elongate member is provided with a locator member slidably associated therewith and said locator member is provided with one or more expandable positioning elements on its distal portion, comprising the steps of advancing the locator member distally from the distal end of the elongate member; expanding the said one or more positioning elements; and withdrawing said locator member until said positioning elements contact the wall of the blood vessel; the step of withdrawing the locator member being performed prior to the step of deploying the closure element.
  • 18. A method for delivering a closure element to seal an opening through tissue beneath a patient's skin the closure element being carried by a carrier assembly slidable on the outer surface of an elongate member, the elongate member being at least partially located within a sleeve member having a proximal end disposed proximate the carrier assembly and a distal end disposed proximate a distal end of the elongate member, the method comprising: inserting a distal end of the sleeve member through the patient's skin and into an opening through tissue which opening is in blood flow communication with a lumen of a blood vessel;following locating one or more positioning elements of a locator member in contact with the tissue, advancing the carrier assembly carrying the closure element towards the distal end of the elongate member from a location distal the patient's skin and distal the opening through tissue, the advancement of the carrier assembly causing the sleeve member to be expanded from the proximal end of the sleeve member toward the distal end of the sleeve member to permit such advancement; anddeploying the closure element from the carrier assembly to substantially seal said opening, the closure element including one or more tines engaging the tissue and remaining within the tissue.
  • 19. The method of claim 18, wherein said blood vessel is the femoral artery.
  • 20. The method of claim 18, wherein the elongate member is provided with a locator member slidably associated therewith and said locator member is provided with one or more expandable positioning elements on its distal portion, comprising the steps of advancing the locator member distally from the distal end of the elongate member; expanding the said one or more positioning elements; and withdrawing said locator member until said positioning elements contact the wall of the blood vessel; the step of withdrawing the locator member being performed prior to the step of deploying the closure element.
RELATED INFORMATION

This application is a continuation of U.S. application Ser. No. 10/081,725 now U.S. Pat. No. 6,749,621, filed on Feb. 21, 2002. The priority of the prior application is expressly claimed, and the disclosure of this application is hereby incorporated by reference in its entirety.

US Referenced Citations (1046)
Number Name Date Kind
287046 Norton Oct 1883 A
438400 Brennen Oct 1890 A
556082 Boeddinghaus Mar 1896 A
1088393 Backus Feb 1914 A
1242139 Callahan Oct 1917 A
1331401 Summers Feb 1920 A
1426111 Sacker Aug 1922 A
1480935 Gleason Jan 1924 A
1516990 Silverman Nov 1924 A
1596004 De Bengoa Aug 1926 A
1647958 Ciarlante Nov 1927 A
1847347 Maisto Mar 1932 A
1852098 Anderson Apr 1932 A
1880569 Weis Oct 1932 A
2075508 Davidson Mar 1937 A
2087074 Tucker Jul 1937 A
2108206 Meeker Feb 1938 A
2210061 Caminez Aug 1940 A
2254620 Miller Sep 1941 A
2316297 Southerland et al. Apr 1943 A
2371978 Perham Mar 1945 A
2453227 James Nov 1948 A
2583625 Bergan Jan 1952 A
2610631 Calicchio Sep 1952 A
2684070 Kelsey Jul 1954 A
2755699 Forster Jul 1956 A
2910067 White Oct 1959 A
2944311 Schneckenberger Jul 1960 A
2951482 Sullivan Sep 1960 A
2969887 Darmstadt et al. Jan 1961 A
3014483 McCarthy Dec 1961 A
3015403 Fuller Jan 1962 A
3113379 Frank Dec 1963 A
3120230 Skold Feb 1964 A
3142878 Santora Aug 1964 A
3209754 Brown Oct 1965 A
3348595 Stevens, Jr. Oct 1967 A
3357070 Sloan Dec 1967 A
3482428 Kapitanov et al. Dec 1969 A
3494533 Green et al. Feb 1970 A
3510923 Blake May 1970 A
3513848 Winston et al. May 1970 A
3523351 Filia Aug 1970 A
3525340 Gilbert Aug 1970 A
3586002 Wood Jun 1971 A
3604425 Le Roy Sep 1971 A
3618447 Goins Nov 1971 A
3664345 Dabbs et al. May 1972 A
3677243 Nerz Jul 1972 A
3682180 McFarlane Aug 1972 A
3732719 Pallotta May 1973 A
3750650 Ruttgers Aug 1973 A
3753438 Wood et al. Aug 1973 A
3757629 Schneider Sep 1973 A
3805337 Branstetter Apr 1974 A
3814104 Irnich et al. Jun 1974 A
3823719 Cummings Jul 1974 A
3828791 Santos Aug 1974 A
3831608 Kletschka et al. Aug 1974 A
3856016 Davis Dec 1974 A
3874388 King et al. Apr 1975 A
3908662 Razgulov et al. Sep 1975 A
3926194 Greenberg et al. Dec 1975 A
3931821 Kletschka et al. Jan 1976 A
3939820 Grayzel Feb 1976 A
3944114 Coppens Mar 1976 A
3960147 Murray Jun 1976 A
3976079 Samuels et al. Aug 1976 A
3985138 Jarvik Oct 1976 A
4007743 Blake Feb 1977 A
4011872 Komiya Mar 1977 A
4014492 Rothfuss Mar 1977 A
4018228 Goosen Apr 1977 A
4047533 Perciaccante et al. Sep 1977 A
4064881 Meredith Dec 1977 A
4112944 Williams Sep 1978 A
4153321 Pombrol May 1979 A
4162673 Patel Jul 1979 A
4169476 Hiltebrandt Oct 1979 A
4189808 Brown Feb 1980 A
4192315 Hilzinger et al. Mar 1980 A
4201215 Crossett et al. May 1980 A
4204541 Kapitanov May 1980 A
4207870 Eldridge Jun 1980 A
4214587 Sakura, Jr. Jul 1980 A
4215699 Patel Aug 1980 A
4217902 March Aug 1980 A
4267995 McMillan May 1981 A
4273129 Boebel Jun 1981 A
4274415 Kanamoto et al. Jun 1981 A
4278091 Borzone Jul 1981 A
4287489 Pinkham Sep 1981 A
4291698 Fuchs et al. Sep 1981 A
4317445 Robinson Mar 1982 A
4317451 Cerwin et al. Mar 1982 A
4318401 Zimmerman Mar 1982 A
4327485 Rix May 1982 A
4345606 Littleford Aug 1982 A
4359052 Staub Nov 1982 A
4368736 Kaster Jan 1983 A
4387489 Dudek Jun 1983 A
4396139 Hall et al. Aug 1983 A
4400879 Hildreth Aug 1983 A
4407286 Noiles et al. Oct 1983 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4428376 Mericle Jan 1984 A
4440170 Golden et al. Apr 1984 A
4449531 Cerwin et al. May 1984 A
4475544 Reis Oct 1984 A
4480356 Martin Nov 1984 A
4485816 Krumme Dec 1984 A
4501276 Lombardi Feb 1985 A
RE31855 Osborn Mar 1985 E
4505273 Braun et al. Mar 1985 A
4505274 Speelman Mar 1985 A
4523591 Kaplan et al. Jun 1985 A
4523695 Braun et al. Jun 1985 A
4525157 Valaincourt Jun 1985 A
4526174 Froehlich Jul 1985 A
4577635 Meredith Mar 1986 A
4586503 Kirsch et al. May 1986 A
4592498 Braun et al. Jun 1986 A
4596559 Fleischhacker Jun 1986 A
4607638 Crainich Aug 1986 A
4610251 Kumar Sep 1986 A
4610252 Catalano Sep 1986 A
4635634 Santos Jan 1987 A
4644956 Morgenstern Feb 1987 A
4651737 Deniega Mar 1987 A
4664305 Blake, III et al. May 1987 A
4665906 Jervis May 1987 A
4667675 Davis May 1987 A
4683895 Pohndorf Aug 1987 A
4687469 Osypka Aug 1987 A
4693249 Schenck et al. Sep 1987 A
4697312 Freyer Oct 1987 A
4719917 Barrows et al. Jan 1988 A
4724840 McVay et al. Feb 1988 A
4738658 Magro et al. Apr 1988 A
4744364 Kensey May 1988 A
4747407 Liu et al. May 1988 A
4750492 Jacobs Jun 1988 A
4759364 Boebel Jul 1988 A
4771782 Millar Sep 1988 A
4772266 Groshong Sep 1988 A
4773421 Davis Sep 1988 A
4777950 Kees, Jr. Oct 1988 A
4789090 Blake, III Dec 1988 A
4813586 Seifert Mar 1989 A
4823794 Pierce Apr 1989 A
4830002 Semm May 1989 A
4832688 Sagae et al. May 1989 A
4836204 Landymore et al. Jun 1989 A
4852568 Kensey Aug 1989 A
4860746 Yoon Aug 1989 A
4865026 Barrett Sep 1989 A
4866818 Thompson Sep 1989 A
4874122 Froelich et al. Oct 1989 A
4878915 Brantigan Nov 1989 A
4885003 Hillstead Dec 1989 A
4886067 Palermo Dec 1989 A
4887601 Richards Dec 1989 A
4890612 Kensey Jan 1990 A
4902508 Badylak et al. Feb 1990 A
4917087 Walsh et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4929240 Kirsch et al. May 1990 A
4934364 Green Jun 1990 A
4950258 Kawai et al. Aug 1990 A
4957499 Lipatov et al. Sep 1990 A
4961729 Vaillancourt Oct 1990 A
4967949 Sandhaus Nov 1990 A
4976721 Blasnik et al. Dec 1990 A
4983176 Cushman et al. Jan 1991 A
4997436 Oberlander Mar 1991 A
4997439 Chen Mar 1991 A
5002562 Oberlander Mar 1991 A
5007921 Brown Apr 1991 A
5009663 Broomé Apr 1991 A
5015247 Michelson May 1991 A
5021059 Kensey et al. Jun 1991 A
5026390 Brown Jun 1991 A
5030226 Green et al. Jul 1991 A
5032127 Frazee et al. Jul 1991 A
5035692 Lyon et al. Jul 1991 A
5047047 Yoon Sep 1991 A
5053008 Bajaj Oct 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5071430 de Salis et al. Dec 1991 A
5078731 Hayhurst Jan 1992 A
5092941 Miura Mar 1992 A
5100418 Yoon et al. Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5108420 Marks Apr 1992 A
5108421 Fowler Apr 1992 A
5114032 Laidlaw May 1992 A
5114065 Storace May 1992 A
5116349 Aranyi May 1992 A
5122122 Allgood Jun 1992 A
5122156 Granger et al. Jun 1992 A
5131379 Sewell, Jr. Jul 1992 A
5141520 Goble et al. Aug 1992 A
5147381 Heimerl et al. Sep 1992 A
5156609 Nakao et al. Oct 1992 A
5158566 Pianetti Oct 1992 A
5160339 Chen et al. Nov 1992 A
5163343 Gish Nov 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5167643 Lynn Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171250 Yoon Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5176648 Holmes et al. Jan 1993 A
5176682 Chow Jan 1993 A
5176691 Pierce Jan 1993 A
5192287 Fournier et al. Mar 1993 A
5192288 Thompson et al. Mar 1993 A
5192300 Fowler Mar 1993 A
5192301 Kamiya et al. Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5192602 Spencer et al. Mar 1993 A
5193533 Body et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5203787 Noblitt et al. Apr 1993 A
5207697 Carusillo et al. May 1993 A
5209756 Seedhorm et al. May 1993 A
5217024 Dorsey et al. Jun 1993 A
5217471 Burkhart Jun 1993 A
5219359 McQuilkin et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5226908 Yoon Jul 1993 A
5234449 Bruker et al. Aug 1993 A
5236435 Sewell, Jr. Aug 1993 A
5236445 Hayhurst et al. Aug 1993 A
5237996 Waldman Aug 1993 A
5242456 Nash et al. Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5242459 Buelna Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5250058 Miller et al. Oct 1993 A
5254105 Haaga Oct 1993 A
5255679 Imran Oct 1993 A
5258015 Li et al. Nov 1993 A
5269792 Kovac et al. Dec 1993 A
5275616 Fowler Jan 1994 A
5281422 Badylak et al. Jan 1994 A
5282808 Kovac et al. Feb 1994 A
5282827 Kensey et al. Feb 1994 A
5282832 Toso et al. Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290243 Chodorow et al. Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292309 Van Tassel et al. Mar 1994 A
5292332 Lee Mar 1994 A
5304183 Gourlay et al. Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304204 Bregen Apr 1994 A
5306254 Nash et al. Apr 1994 A
5306280 Bregen et al. Apr 1994 A
5309927 Welch May 1994 A
5318542 Hirsch et al. Jun 1994 A
5320639 Rudnick Jun 1994 A
5327908 Gerry Jul 1994 A
5330442 Green et al. Jul 1994 A
5330445 Haaga Jul 1994 A
5330503 Yoon Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5334217 Das Aug 1994 A
5335680 Moore Aug 1994 A
5340360 Stefanchik Aug 1994 A
5342393 Stack Aug 1994 A
5344439 Otten Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354279 Hofling Oct 1994 A
5364406 Sewell, Jr. Nov 1994 A
5364408 Gordon Nov 1994 A
5366458 Korthoff et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5376101 Green et al. Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5391173 Wilk Feb 1995 A
5392978 Velez et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5403330 Tuason Apr 1995 A
5403331 Chesterfield et al. Apr 1995 A
5404621 Heinke Apr 1995 A
5409499 Yi Apr 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5413584 Schulze May 1995 A
5416584 Kay May 1995 A
5417699 Klein et al. May 1995 A
5419765 Weldon et al. May 1995 A
5419777 Hofling May 1995 A
5421832 Lefebvre Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5425489 Shichman et al. Jun 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5431639 Shaw Jul 1995 A
5431667 Thompson et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437631 Janzen Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443481 Lee Aug 1995 A
5445167 Yoon et al. Aug 1995 A
5449359 Groiso Sep 1995 A
5451235 Lock et al. Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5462558 Kolesa et al. Oct 1995 A
5462561 Voda Oct 1995 A
5464413 Siska, Jr. et al. Nov 1995 A
5466241 Leroy et al. Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471982 Edwards et al. Dec 1995 A
5474557 Mai Dec 1995 A
5474569 Zinreich et al. Dec 1995 A
5474572 Hayhurst Dec 1995 A
5476505 Limon Dec 1995 A
5478352 Fowler Dec 1995 A
5478353 Yoon et al. Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5486195 Myers et al. Jan 1996 A
5492119 Abrams Feb 1996 A
5497933 DeFonzo et al. Mar 1996 A
5501698 Roth et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5514159 Matula et al. May 1996 A
5521184 Zimmerman May 1996 A
5522840 Krajicek Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5536267 Edwards Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5540716 Hlavacek Jul 1996 A
5543520 Zimmerman Aug 1996 A
5544802 Crainich Aug 1996 A
5547474 Kloeckl et al. Aug 1996 A
5560532 DeFonzo et al. Oct 1996 A
5562684 Kammerer Oct 1996 A
5571120 Yoon Nov 1996 A
5573540 Yoon Nov 1996 A
5573784 Badylak et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5584879 Reimold et al. Dec 1996 A
5591205 Fowler Jan 1997 A
5593412 Martinez et al. Jan 1997 A
5593422 Muijs Van der Moer et al. Jan 1997 A
5593425 Bonutti et al. Jan 1997 A
5601602 Fowler Feb 1997 A
5609597 Lehrer Mar 1997 A
5611986 Datta et al. Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5613975 Christy Mar 1997 A
5618291 Thompson et al. Apr 1997 A
5618306 Roth et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5620461 Muijs et al. Apr 1997 A
5626614 Hart May 1997 A
5630824 Hart May 1997 A
5634936 Lindon et al. Jun 1997 A
5643318 Tsukernik et al. Jul 1997 A
5645553 Kolesa et al. Jul 1997 A
5645565 Rudd et al. Jul 1997 A
5645566 Brenneman et al. Jul 1997 A
5645567 Crainich Jul 1997 A
5647372 Tovey et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
D383539 Croley Sep 1997 S
5669917 Sauer et al. Sep 1997 A
5669935 Rosenman et al. Sep 1997 A
5672174 Gough et al. Sep 1997 A
5674231 Green et al. Oct 1997 A
5676689 Kensey et al. Oct 1997 A
5676974 Valdes et al. Oct 1997 A
5681280 Rusk et al. Oct 1997 A
5681334 Evans et al. Oct 1997 A
5681351 Jamiolkowski et al. Oct 1997 A
5683405 Yacoubian et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5693061 Pierce et al. Dec 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5700273 Buelna et al. Dec 1997 A
5709224 Behl et al. Jan 1998 A
5709708 Thal Jan 1998 A
5713899 Marnay et al. Feb 1998 A
5715987 Kelley et al. Feb 1998 A
5716375 Fowler Feb 1998 A
5720755 Dakov Feb 1998 A
5720765 Thal Feb 1998 A
5725498 Janzen et al. Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5725556 Moser et al. Mar 1998 A
5728109 Schulze et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728114 Evans et al. Mar 1998 A
5728116 Rosenman Mar 1998 A
5728122 Leschinsky et al. Mar 1998 A
5728132 Van Tassel et al. Mar 1998 A
5728133 Kontos Mar 1998 A
5728143 Gough et al. Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5735736 Volk Apr 1998 A
5735873 MacLean Apr 1998 A
5735875 Bonutti et al. Apr 1998 A
5735877 Pagedas Apr 1998 A
5749826 Faulkner May 1998 A
5749898 Schulze et al. May 1998 A
5752966 Chang May 1998 A
5755726 Pratt et al. May 1998 A
5755778 Kleshinski May 1998 A
5759189 Ferragamo et al. Jun 1998 A
5766217 Christy Jun 1998 A
5766246 Mulhauser et al. Jun 1998 A
5769862 Kammerer et al. Jun 1998 A
5769870 Salahieh et al. Jun 1998 A
5776147 Dolendo Jul 1998 A
5776150 Nolan et al. Jul 1998 A
5779707 Bertholet et al. Jul 1998 A
5780807 Saunders Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5782861 Cragg et al. Jul 1998 A
5782864 Lizardi Jul 1998 A
5795958 Rao et al. Aug 1998 A
5797928 Kogasaka Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797933 Snow et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810776 Bacich et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810851 Yoon Sep 1998 A
5810877 Roth et al. Sep 1998 A
5814069 Schulze et al. Sep 1998 A
5817113 Gifford Oct 1998 A
5820631 Nobles Oct 1998 A
5827298 Hart et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5830221 Stein et al. Nov 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5843167 Dwyer et al. Dec 1998 A
5845657 Carberry et al. Dec 1998 A
5846254 Schulze et al. Dec 1998 A
5853421 Leschinsky et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855312 Toledano Jan 1999 A
5855576 LeVeen et al. Jan 1999 A
5858082 Cruz et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5868755 Kanner et al. Feb 1999 A
5868762 Cragg et al. Feb 1999 A
5868763 Spence et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5871490 Schulze et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873876 Christy Feb 1999 A
5873891 Sohn Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5891088 Thompson et al. Apr 1999 A
5893592 Schulze et al. Apr 1999 A
5897487 Ouchi Apr 1999 A
5902310 Foerster et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5906631 Imran May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5910155 Ratcliff et al. Jun 1999 A
5919207 Taheri Jul 1999 A
5919208 Valenti Jul 1999 A
5922009 Epstein et al. Jul 1999 A
5928231 Klein et al. Jul 1999 A
5928251 Aranyi et al. Jul 1999 A
5935147 Kensey et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5948001 Larsen Sep 1999 A
5951518 Licata et al. Sep 1999 A
5951547 Gough et al. Sep 1999 A
5951575 Bolduc et al. Sep 1999 A
5951576 Wakabayashi Sep 1999 A
5951589 Epstein et al. Sep 1999 A
5957900 Ouchi Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5957938 Zhu et al. Sep 1999 A
5957940 Tanner et al. Sep 1999 A
5964782 LaFontaine et al. Oct 1999 A
5976159 Bolduc et al. Nov 1999 A
5976161 Kirsch et al. Nov 1999 A
5980517 Gough et al. Nov 1999 A
5984934 Ashby et al. Nov 1999 A
5984948 Hasson Nov 1999 A
5984949 Levin Nov 1999 A
5993466 Yoon Nov 1999 A
5993468 Rygaard Nov 1999 A
5993476 Groiso Nov 1999 A
6001110 Adams Dec 1999 A
6004341 Zhu et al. Dec 1999 A
6007563 Nash et al. Dec 1999 A
6009877 Edwards Jan 2000 A
6010517 Baccaro Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015815 Mollison Jan 2000 A
6019779 Thorud et al. Feb 2000 A
6022372 Kontos Feb 2000 A
6024747 Kontos Feb 2000 A
6024750 Mastri Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6024758 Thal Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033427 Lee Mar 2000 A
6036703 Evans et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6045570 Epstein et al. Apr 2000 A
6048358 Barak Apr 2000 A
6056744 Edwards May 2000 A
6056768 Cates et al. May 2000 A
6056769 Epstein et al. May 2000 A
6056770 Epstein et al. May 2000 A
6059800 Hart et al. May 2000 A
6059825 Hobbs et al. May 2000 A
6063085 Tay et al. May 2000 A
6063114 Nash et al. May 2000 A
6066160 Colvin et al. May 2000 A
6068603 Suzuki May 2000 A
6071300 Brenneman et al. Jun 2000 A
6074409 Goldfarb Jun 2000 A
6077281 Das Jun 2000 A
6077291 Das Jun 2000 A
6080182 Shaw Jun 2000 A
6080183 Tsugita et al. Jun 2000 A
6083242 Cook Jul 2000 A
6086608 Ek et al. Jul 2000 A
6090130 Nash et al. Jul 2000 A
6092561 Schmid Jul 2000 A
6095155 Criscuolo Aug 2000 A
6099553 Hart et al. Aug 2000 A
6102271 Longo et al. Aug 2000 A
6106545 Egan Aug 2000 A
6110184 Weadock Aug 2000 A
6113610 Poncet Sep 2000 A
6113612 Swanson et al. Sep 2000 A
6117125 Rothbarth et al. Sep 2000 A
6117148 Ravo Sep 2000 A
6117157 Tekulve Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6120524 Taheri Sep 2000 A
6126675 Schervinsky et al. Oct 2000 A
6126677 Ganaja et al. Oct 2000 A
6136010 Modesitt et al. Oct 2000 A
6143004 Davis Nov 2000 A
6143017 Thal Nov 2000 A
6146385 Torrie et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6149667 Hovland et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152934 Harper et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6159234 Bonutti et al. Dec 2000 A
6161263 Anderson Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6171277 Ponzi Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6174324 Egan et al. Jan 2001 B1
6179849 Yencho et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6193708 Ken et al. Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6206895 Levinson Mar 2001 B1
6206913 Yencho et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6210407 Webster Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6221084 Fleenor Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6231592 Bonutti et al. May 2001 B1
6245079 Nobles et al. Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6254615 Bolduc et al. Jul 2001 B1
6254617 Spence et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6267773 Gadberry et al. Jul 2001 B1
6273903 Wilk Aug 2001 B1
6277140 Ginn et al. Aug 2001 B2
6280460 Bolduc et al. Aug 2001 B1
6287322 Zhu et al. Sep 2001 B1
6296657 Brucker Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6306081 Ishikawa et al. Oct 2001 B1
6309416 Swanson et al. Oct 2001 B1
6319258 McAllen, III et al. Nov 2001 B1
6322580 Kanner Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6329386 Mollison Dec 2001 B1
6334865 Redmond et al. Jan 2002 B1
6348064 Kanner Feb 2002 B1
6355052 Neuss et al. Mar 2002 B1
6358258 Arcia et al. Mar 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
D457958 Dycus May 2002 S
6383208 Sancoff et al. May 2002 B1
6391048 Ginn et al. May 2002 B1
6395015 Borst et al. May 2002 B1
6397110 Kuzma May 2002 B1
6398752 Sweezer et al. Jun 2002 B1
6402765 Monassevitch et al. Jun 2002 B1
6409739 Nobles et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6421899 Zitnay Jul 2002 B1
6423054 Ouchi Jul 2002 B1
6425911 Akerfeldt et al. Jul 2002 B1
6428472 Haas Aug 2002 B1
6428548 Durgin et al. Aug 2002 B1
6443158 Lafontaine et al. Sep 2002 B1
6443963 Baldwin et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450391 Kayan et al. Sep 2002 B1
6458130 Frazier et al. Oct 2002 B1
6461364 Ginn et al. Oct 2002 B1
6461366 Seguin Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488692 Spence et al. Dec 2002 B1
6500115 Krattiger et al. Dec 2002 B2
6506210 Kanner Jan 2003 B1
6508828 Akerfeldt et al. Jan 2003 B1
6514280 Gilson Feb 2003 B1
6517498 Burbank et al. Feb 2003 B1
6517555 Caro Feb 2003 B1
6517569 Mikus et al. Feb 2003 B2
6527737 Kaneshige Mar 2003 B2
6533762 Kanner et al. Mar 2003 B2
6533812 Swanson et al. Mar 2003 B2
6537288 Vargas et al. Mar 2003 B2
6547806 Ding Apr 2003 B1
6551319 Lieberman Apr 2003 B2
6558349 Kirkman May 2003 B1
6569159 Edwards et al. May 2003 B1
6569173 Blatter et al. May 2003 B1
6569185 Ungs May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6578585 Stachowski et al. Jun 2003 B1
6582452 Coleman et al. Jun 2003 B2
6582482 Gillman et al. Jun 2003 B2
6596012 Akerfeldt et al. Jul 2003 B2
6599303 Peterson et al. Jul 2003 B1
6599311 Biggs et al. Jul 2003 B1
6602263 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613059 Schaller et al. Sep 2003 B2
6613060 Adams et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6620165 Wellisz Sep 2003 B2
6623509 Ginn Sep 2003 B2
6623510 Carley et al. Sep 2003 B2
6626918 Ginn et al. Sep 2003 B1
6626919 Swanstrom Sep 2003 B1
6626920 Whayne Sep 2003 B2
6632197 Lyon Oct 2003 B2
6632238 Ginn et al. Oct 2003 B2
6634537 Chen Oct 2003 B2
6645205 Ginn Nov 2003 B2
6645225 Atkinson Nov 2003 B1
6652538 Kayan et al. Nov 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663633 Pierson, III Dec 2003 B1
6663655 Ginn et al. Dec 2003 B2
6669714 Coleman et al. Dec 2003 B2
6673083 Kayan et al. Jan 2004 B1
6676671 Robertson et al. Jan 2004 B2
6676685 Pedros et al. Jan 2004 B2
6679904 Gleeson et al. Jan 2004 B2
6685707 Roman et al. Feb 2004 B2
6689051 Nakada et al. Feb 2004 B2
6689147 Koster, Jr. Feb 2004 B1
6695867 Ginn et al. Feb 2004 B2
6699256 Logan et al. Mar 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6712837 Akerfeldt et al. Mar 2004 B2
6719777 Ginn et al. Apr 2004 B2
6726704 Loshakove et al. Apr 2004 B1
6736822 McClellan et al. May 2004 B2
6743195 Zucker Jun 2004 B2
6743243 Roy et al. Jun 2004 B1
6743259 Ginn Jun 2004 B2
6745079 King Jun 2004 B2
6746457 Dana et al. Jun 2004 B2
6746472 Frazier et al. Jun 2004 B2
6749621 Pantages et al. Jun 2004 B2
6749622 McGuckin et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755842 Kanner et al. Jun 2004 B2
6767356 Kanner et al. Jul 2004 B2
6776785 Yencho et al. Aug 2004 B1
6780197 Roe et al. Aug 2004 B2
6786915 Akerfeldt et al. Sep 2004 B2
6790218 Jayaraman Sep 2004 B2
6790220 Morris et al. Sep 2004 B2
6837893 Miller Jan 2005 B2
6837906 Ginn Jan 2005 B2
6846319 Ginn et al. Jan 2005 B2
6849078 Durgin et al. Feb 2005 B2
6860895 Akerfeldt et al. Mar 2005 B1
6890343 Ginn et al. May 2005 B2
6896687 Dakov May 2005 B2
6896692 Ginn et al. May 2005 B2
6904647 Byers, Jr. Jun 2005 B2
6913607 Ainsworth et al. Jul 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6926731 Coleman et al. Aug 2005 B2
6929634 Dorros et al. Aug 2005 B2
6942641 Seddon Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6942691 Chuter Sep 2005 B1
6964668 Modesitt et al. Nov 2005 B2
6969397 Ginn Nov 2005 B2
6984238 Gifford, III et al. Jan 2006 B2
6989003 Wing et al. Jan 2006 B2
6989016 Tallarida et al. Jan 2006 B2
7001398 Carley et al. Feb 2006 B2
7001400 Modesitt et al. Feb 2006 B1
7008435 Cummins Mar 2006 B2
7008439 Janzen et al. Mar 2006 B1
7025776 Houser et al. Apr 2006 B1
7033379 Peterson Apr 2006 B2
7048747 Arcia et al. May 2006 B2
7060084 Loshakove et al. Jun 2006 B1
7063661 Okada Jun 2006 B2
7063711 Loshakove et al. Jun 2006 B1
7074232 Kanner et al. Jul 2006 B2
7076305 Imran et al. Jul 2006 B2
7083635 Ginn Aug 2006 B2
7087064 Hyde Aug 2006 B1
7108709 Cummins Sep 2006 B2
7108710 Anderson Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7112225 Ginn Sep 2006 B2
7122002 Okada Oct 2006 B2
7144411 Ginn et al. Dec 2006 B2
7147646 Dana et al. Dec 2006 B2
7163551 Anthony et al. Jan 2007 B2
7169158 Sniffin et al. Jan 2007 B2
7169164 Borillo et al. Jan 2007 B2
7211101 Carley et May 2007 B2
7229452 Kayan Jun 2007 B2
7261716 Strobel et al. Aug 2007 B2
7270672 Singer Sep 2007 B1
7306614 Weller et al. Dec 2007 B2
7311720 Mueller et al. Dec 2007 B2
7316704 Bagaoisan et al. Jan 2008 B2
7316706 Bloom et al. Jan 2008 B2
7322995 Bechman et al. Jan 2008 B2
7326230 Ravikumar Feb 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7335220 Khosravi et al. Feb 2008 B2
D566272 Walberg et al. Apr 2008 S
7361178 Hearn et al. Apr 2008 B2
7361183 Ginn Apr 2008 B2
7361185 O'Malley et al. Apr 2008 B2
7393363 Ginn Jul 2008 B2
7396359 Derowe et al. Jul 2008 B1
7431727 Cole et al. Oct 2008 B2
7431729 Chanduszko Oct 2008 B2
7465286 Patterson et al. Dec 2008 B2
7507200 Okada Mar 2009 B2
7533790 Knodel et al. May 2009 B1
7582103 Young et al. Sep 2009 B2
7582104 Corcoran et al. Sep 2009 B2
7597706 Kanner et al. Oct 2009 B2
7618427 Ortiz et al. Nov 2009 B2
7622628 Bergin et al. Nov 2009 B2
7645285 Cosgrove et al. Jan 2010 B2
D611144 Reynolds Mar 2010 S
7727249 Rahmani Jun 2010 B2
7731655 Smith et al. Jun 2010 B2
7749249 Gelbart et al. Jul 2010 B2
7780696 Daniel et al. Aug 2010 B2
7799042 Williamson, IV et al. Sep 2010 B2
7819895 Ginn et al. Oct 2010 B2
7931671 Tenerz Apr 2011 B2
7967842 Bakos Jun 2011 B2
8103327 Harlev et al. Jan 2012 B2
8105352 Egnelov Jan 2012 B2
8226666 Zarbatany et al. Jul 2012 B2
20010007077 Ginn et al. Jul 2001 A1
20010031972 Robertson et al. Oct 2001 A1
20010031973 Nobles et al. Oct 2001 A1
20010044639 Levinson Nov 2001 A1
20010046518 Sawhney Nov 2001 A1
20010047180 Grudem et al. Nov 2001 A1
20010053909 Nakada Dec 2001 A1
20020026208 Belef et al. Feb 2002 A1
20020026215 Redmond et al. Feb 2002 A1
20020026216 Grimes Feb 2002 A1
20020029050 Gifford, III et al. Mar 2002 A1
20020038127 Blatter et al. Mar 2002 A1
20020042622 Vargas et al. Apr 2002 A1
20020049427 Wiener et al. Apr 2002 A1
20020049472 Coleman et al. Apr 2002 A1
20020058960 Hudson et al. May 2002 A1
20020072768 Ginn Jun 2002 A1
20020077657 Ginn et al. Jun 2002 A1
20020082641 Ginn et al. Jun 2002 A1
20020095181 Beyar Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020106409 Sawhney et al. Aug 2002 A1
20020107542 Kanner et al. Aug 2002 A1
20020133193 Ginn et al. Sep 2002 A1
20020151921 Kanner et al. Oct 2002 A1
20020151963 Brown et al. Oct 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020188275 McGuckin et al. Dec 2002 A1
20020193808 Belef et al. Dec 2002 A1
20020198562 Akerfeldt et al. Dec 2002 A1
20020198589 Leong Dec 2002 A1
20030004543 Gleeson et al. Jan 2003 A1
20030009180 Hinchliffe et al. Jan 2003 A1
20030009196 Peterson Jan 2003 A1
20030023248 Parodi Jan 2003 A1
20030032981 Kanner et al. Feb 2003 A1
20030033006 Phillips et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030055455 Yang et al. Mar 2003 A1
20030060846 Egnelov et al. Mar 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030078598 Ginn et al. Apr 2003 A1
20030083679 Grudem et al. May 2003 A1
20030093096 McGuckin et al. May 2003 A1
20030097140 Kanner May 2003 A1
20030109890 Kanner et al. Jun 2003 A1
20030125766 Ding Jul 2003 A1
20030144695 McGuckin, Jr. et al. Jul 2003 A1
20030158577 Pantages et al. Aug 2003 A1
20030158578 Pantages et al. Aug 2003 A1
20030195504 Tallarida et al. Oct 2003 A1
20030195561 Carley et al. Oct 2003 A1
20030208211 Kortenbach Nov 2003 A1
20030233095 Urbanski et al. Dec 2003 A1
20040009205 Sawhney Jan 2004 A1
20040009289 Carley et al. Jan 2004 A1
20040010285 Carley et al. Jan 2004 A1
20040039414 Carley et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040059376 Breuniger Mar 2004 A1
20040068273 Fariss et al. Apr 2004 A1
20040073236 Carley et al. Apr 2004 A1
20040073255 Ginn et al. Apr 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040082906 Tallarida et al. Apr 2004 A1
20040087985 Loshakove et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040092964 Modesitt et al. May 2004 A1
20040092968 Caro et al. May 2004 A1
20040092973 Chandusko et al. May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040093027 Fabisiak et al. May 2004 A1
20040097978 Modesitt et al. May 2004 A1
20040106980 Solovay et al. Jun 2004 A1
20040127940 Ginn et al. Jul 2004 A1
20040143290 Brightbill Jul 2004 A1
20040143291 Corcoran et al. Jul 2004 A1
20040153122 Palermo Aug 2004 A1
20040153123 Palermo et al. Aug 2004 A1
20040158127 Okada Aug 2004 A1
20040158287 Cragg et al. Aug 2004 A1
20040158309 Wachter et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040191277 Sawhney et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040243216 Gregorich Dec 2004 A1
20040249412 Snow et al. Dec 2004 A1
20040254591 Kanner et al. Dec 2004 A1
20040267193 Bagaoisan et al. Dec 2004 A1
20040267308 Bagaoisan et al. Dec 2004 A1
20040267312 Kanner et al. Dec 2004 A1
20050038460 Jayaraman Feb 2005 A1
20050038500 Boylan et al. Feb 2005 A1
20050059982 Zung et al. Mar 2005 A1
20050075665 Brenzel et al. Apr 2005 A1
20050085851 Fiehler et al. Apr 2005 A1
20050085854 Ginn Apr 2005 A1
20050085855 Forsberg Apr 2005 A1
20050090859 Ravlkumar Apr 2005 A1
20050119695 Carley et al. Jun 2005 A1
20050121042 Belhe et al. Jun 2005 A1
20050149117 Khosravi et al. Jul 2005 A1
20050152949 Hotchkiss et al. Jul 2005 A1
20050154401 Weldon et al. Jul 2005 A1
20050165357 McGuckin et al. Jul 2005 A1
20050169974 Tenerez et al. Aug 2005 A1
20050177189 Ginn et al. Aug 2005 A1
20050187564 Jayaraman Aug 2005 A1
20050203552 Laufer et al. Sep 2005 A1
20050216057 Coleman et al. Sep 2005 A1
20050222614 Ginn et al. Oct 2005 A1
20050228443 Yassinzadeh Oct 2005 A1
20050234508 Cummins et al. Oct 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050267528 Ginn et al. Dec 2005 A1
20050267530 Cummins et al. Dec 2005 A1
20050273136 Belef et al. Dec 2005 A1
20050273137 Ginn Dec 2005 A1
20050274768 Cummins et al. Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060020270 Jabba et al. Jan 2006 A1
20060030867 Zadno Feb 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060047313 Khanna et al. Mar 2006 A1
20060058844 White et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060089635 Young et al. Apr 2006 A1
20060095029 Young et al. May 2006 A1
20060100664 Pai et al. May 2006 A1
20060135989 Carley et al. Jun 2006 A1
20060142784 Kontos Jun 2006 A1
20060144479 Carley et al. Jul 2006 A1
20060167484 Carley et al. Jul 2006 A1
20060190014 Ginn et al. Aug 2006 A1
20060190036 Wendel et al. Aug 2006 A1
20060190037 Ginn et al. Aug 2006 A1
20060190038 Carley et al. Aug 2006 A1
20060195123 Ginn et al. Aug 2006 A1
20060195124 Ginn et al. Aug 2006 A1
20060206146 Tenerez Sep 2006 A1
20060253037 Ginn et al. Nov 2006 A1
20060253072 Pai et al. Nov 2006 A1
20060259049 Harada et al. Nov 2006 A1
20060265012 Anderson Nov 2006 A1
20060287674 Ginn et al. Dec 2006 A1
20060293698 Douk Dec 2006 A1
20070005093 Cox Jan 2007 A1
20070010853 Ginn et al. Jan 2007 A1
20070010854 Cummins et al. Jan 2007 A1
20070021778 Carly Jan 2007 A1
20070027525 Ben-Muvhar Feb 2007 A1
20070049967 Sibbitt, Jr. et al. Mar 2007 A1
20070049968 Sibbitt, Jr. et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070060895 Sibbitt, Jr. et al. Mar 2007 A1
20070060950 Khosravi et al. Mar 2007 A1
20070060951 Shannon Mar 2007 A1
20070083230 Javois Apr 2007 A1
20070083231 Lee Apr 2007 A1
20070112304 Voss May 2007 A1
20070112365 Hilal et al. May 2007 A1
20070112385 Conlon May 2007 A1
20070123816 Zhu et al. May 2007 A1
20070123817 Khosravi et al. May 2007 A1
20070123936 Goldin et al. May 2007 A1
20070172430 Brito et al. Jul 2007 A1
20070179527 Eskuri et al. Aug 2007 A1
20070185530 Chin-Chen et al. Aug 2007 A1
20070203506 Sibbitt, Jr. et al. Aug 2007 A1
20070203507 McLaughlin et al. Aug 2007 A1
20070213747 Monassevitch et al. Sep 2007 A1
20070225755 Preinitz et al. Sep 2007 A1
20070225756 Preinitz et al. Sep 2007 A1
20070225757 Preinitz et al. Sep 2007 A1
20070225758 Preinitz et al. Sep 2007 A1
20070239209 Fallman Oct 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070265658 Nelson et al. Nov 2007 A1
20070275036 Green, III et al. Nov 2007 A1
20070276488 Wachter et al. Nov 2007 A1
20070282373 Ashby et al. Dec 2007 A1
20080004636 Walberg Jan 2008 A1
20080004640 Ellingwood Jan 2008 A1
20080009794 Bagaoisan et al. Jan 2008 A1
20080033459 Shafi et al. Feb 2008 A1
20080045979 Ma Feb 2008 A1
20080058839 Nobles et al. Mar 2008 A1
20080065151 Ginn Mar 2008 A1
20080065152 Carley Mar 2008 A1
20080086075 Isik et al. Apr 2008 A1
20080093414 Bender et al. Apr 2008 A1
20080114378 Matsushita May 2008 A1
20080114395 Mathisen et al. May 2008 A1
20080177288 Carlson Jul 2008 A1
20080221616 Ginn et al. Sep 2008 A1
20080243148 Mikkaichi et al. Oct 2008 A1
20080243182 Bates et al. Oct 2008 A1
20080287967 Andreas et al. Nov 2008 A1
20080287988 Smith et al. Nov 2008 A1
20080300628 Ellingwood Dec 2008 A1
20080312686 Ellingwood Dec 2008 A1
20080312740 Wachter et al. Dec 2008 A1
20080319475 Clark Dec 2008 A1
20090054912 Heanue et al. Feb 2009 A1
20090105728 Noda et al. Apr 2009 A1
20090112306 Bonsignore et al. Apr 2009 A1
20090137900 Bonner et al. May 2009 A1
20090157101 Reyes et al. Jun 2009 A1
20090157102 Reynolds et al. Jun 2009 A1
20090157103 Walberg et al. Jun 2009 A1
20090171388 Dave et al. Jul 2009 A1
20090187215 Mackiewicz et al. Jul 2009 A1
20090216267 Willard et al. Aug 2009 A1
20090227938 Fasching et al. Sep 2009 A1
20090254119 Sibbitt, Jr. et al. Oct 2009 A1
20090287244 Kokish Nov 2009 A1
20090312789 Kassab et al. Dec 2009 A1
20100114156 Mehl May 2010 A1
20100114159 Roorda et al. May 2010 A1
20100130965 Sibbitt, Jr. May 2010 A1
20100179567 Voss et al. Jul 2010 A1
20100179571 Voss Jul 2010 A1
20100179572 Voss et al. Jul 2010 A1
20100179589 Roorda et al. Jul 2010 A1
20100179590 Fortson et al. Jul 2010 A1
20100185234 Fortson et al. Jul 2010 A1
20100249828 Mavani et al. Sep 2010 A1
20110066163 Cho et al. Mar 2011 A1
20110178548 Tenerz Jul 2011 A1
20110270282 Lemke Nov 2011 A1
20120035630 Roorda Feb 2012 A1
20120245603 Voss Sep 2012 A1
20120245626 Ellingwood et al. Sep 2012 A1
20120310261 Cummins et al. Dec 2012 A1
20130006274 Walberg et al. Jan 2013 A1
Foreign Referenced Citations (139)
Number Date Country
2003297432 Dec 2003 AU
2 339 060 Feb 2000 CA
197 11 288 Jan 1998 DE
297 23 736 U 1 Apr 1999 DE
19859952 Feb 2000 DE
102006056283 Jun 2008 DE
0 386 361 Sep 1990 EP
0 534 696 Mar 1993 EP
0 621 032 Oct 1994 EP
0 756 851 Feb 1997 EP
0 774 237 May 1997 EP
0 858 776 Aug 1998 EP
0 941 697 Sep 1999 EP
1 867 287 Dec 2007 EP
2 443 238 Jul 1980 FR
2 715 290 Jul 1995 FR
2 722 975 Feb 1996 FR
2 768 324 Mar 1999 FR
1 358 466 Jul 1974 GB
2 075 144 Nov 1981 GB
2 397 240 Jul 2004 GB
S 20000722 Oct 2001 IE
S 20000724 Oct 2001 IE
S 20010547 Jul 2002 IE
S 20010815 Jul 2002 IE
S 20010748 Aug 2002 IE
S 20010749 Aug 2002 IE
S 20020452 Dec 2002 IE
S 20020664 Feb 2003 IE
S 20020665 Feb 2003 IE
S 20020451 Jul 2003 IE
S 20020552 Jul 2003 IE
S 20030424 Dec 2003 IE
S 20030490 Jan 2004 IE
S 20040368 Nov 2005 IE
S 20050342 Nov 2005 IE
58-181006 Dec 1983 JP
12 74750 Nov 1989 JP
11500642 Aug 1997 JP
2000102546 Apr 2000 JP
9302140 Jul 1995 NL
171425 Apr 1997 PL
2086192 Aug 1997 RU
197801 Jun 1967 SU
495067 Dec 1975 SU
912155 Mar 1982 SU
1243708 Jul 1986 SU
1324650 Jul 1987 SU
1405828 Jun 1988 SU
1456109 Feb 1989 SU
1560133 Apr 1990 SU
WO 9521573 Aug 1995 WO
WO 9624291 Aug 1996 WO
WO 9707741 Mar 1997 WO
WO 9727897 Aug 1997 WO
WO 9728745 Aug 1997 WO
WO 9806346 Feb 1998 WO
WO 9806448 Feb 1998 WO
WO 9816161 Apr 1998 WO
WO 9817179 Apr 1998 WO
WO 9818389 May 1998 WO
WO 9825508 Jun 1998 WO
WO 9858591 Dec 1998 WO
WO 9921491 May 1999 WO
WO 9940849 Aug 1999 WO
WO 9960941 Dec 1999 WO
WO 9962415 Dec 1999 WO
WO 0006029 Feb 2000 WO
WO 0007505 Feb 2000 WO
WO 0027311 May 2000 WO
WO 0027313 May 2000 WO
WO 0056228 Sep 2000 WO
WO 0071032 Nov 2000 WO
WO 0121058 Mar 2001 WO
WO 0135832 May 2001 WO
WO 0147594 Jul 2001 WO
WO 0149186 Jul 2001 WO
WO 0191628 Dec 2001 WO
WO 0219915 Mar 2002 WO
WO 0219920 Mar 2002 WO
WO 0219922 Mar 2002 WO
WO 0219924 Mar 2002 WO
WO 0228286 Apr 2002 WO
WO 0238055 May 2002 WO
WO 0245593 Jun 2002 WO
WO 0245594 Jun 2002 WO
WO 02062234 Aug 2002 WO
WO 02098302 Dec 2002 WO
WO 03013363 Feb 2003 WO
WO 03013364 Feb 2003 WO
WO 03047434 Jun 2003 WO
WO 03071955 Sep 2003 WO
WO 03071956 Sep 2003 WO
WO 03071957 Sep 2003 WO
WO 03094748 Nov 2003 WO
WO 03101310 Dec 2003 WO
WO 2004004578 Jan 2004 WO
WO 2004012602 Feb 2004 WO
WO 2004060169 Jul 2004 WO
WO 2004069054 Aug 2004 WO
WO 2005000126 Jan 2005 WO
WO 2005006990 Jan 2005 WO
WO 2005041782 May 2005 WO
WO 2005063129 Jul 2005 WO
WO 2005082256 Sep 2005 WO
WO 2005092204 Oct 2005 WO
WO 2005110240 Nov 2005 WO
WO 2005112782 Dec 2005 WO
WO 2005115251 Dec 2005 WO
WO 2005115521 Dec 2005 WO
WO 2006000514 Jan 2006 WO
WO 2006026116 Mar 2006 WO
WO 2006052611 May 2006 WO
WO 2006052612 May 2006 WO
WO 2006078578 Jul 2006 WO
WO 2006083889 Aug 2006 WO
WO 2006115901 Nov 2006 WO
WO 2006115904 Nov 2006 WO
WO 2006118877 Nov 2006 WO
WO 2007005585 Jan 2007 WO
WO 2007025014 Mar 2007 WO
WO 2007025017 Mar 2007 WO
WO 2007025018 Mar 2007 WO
WO 2007025019 Mar 2007 WO
WO 2007081836 Jul 2007 WO
WO 2007088069 Aug 2007 WO
WO 2008031102 Mar 2008 WO
WO 2008036384 Mar 2008 WO
WO 2008074027 Jun 2008 WO
WO 2008150915 Dec 2008 WO
WO 2009079091 Jun 2009 WO
WO 2010031050 Mar 2010 WO
WO 2010062693 Jun 2010 WO
WO 2010081101 Jul 2010 WO
WO 2010081102 Jul 2010 WO
WO 2010081103 Jul 2010 WO
WO 2010081106 Jul 2010 WO
20010527 Jan 2001 ZA
200100528 Jan 2001 ZA
Non-Patent Literature Citations (609)
Entry
PCT Publication No. WO 00/07640, “Vascular Suction Cannula, Dialator and Surgical Stapler”, Feb. 17, 2000.
PCT Publication No. WO 00/56227, entitled “Advanced Closure Device”, Sep. 28, 2000.
PCT Publication No. WO 00/56223 entitled “Vascular Closure Device”, Sep. 28, 2000.
PCT Publication No. WO 99/62408 entitled “Vascular Port Device”, Dec. 9, 1999.
PCT Publication No. WO 98/24374, “Vascular Wound Closure System”, Yong Zhu, et al., Jun. 11, 1998.
PCT Publication No. WO 97/20505, “Vascular Wound Closure Device”, Yong Zhu, et al., Jun. 12, 1997.
“Hand tool for forming telephone connections—comprises pliers with reciprocably driven ram crimping clip around conductors against anvil”, Derwent-ACC-No. 1978-B8090A.
U.S. Appl. No. 09/866,551, filed May 25, 2001.
U.S. Appl. No. 11/396,141, filed Mar. 31, 2006.
U.S. Appl. No. 11/675,462, filed Feb. 15, 2007.
U.S. Appl. No. 11/744,089, filed May 3, 2007.
Database WPI; Section PQ, Week 200120; Derwent Publications Ltd., London GB; AN 2001-203165; XP002199926 & ZA 200 100 528 A (Anthony T), Feb. 28, 2001 abstract.
2002/0072768, Office Action, Aug. 27, 2004.
2002/0072768, Office Action, Feb. 23, 2005.
2002/0072768, Office Action, Apr. 11, 2005.
2002/0072768, Office Action, Jul. 27, 2005.
2002/0072768, Office Action, Mar. 6, 2006.
2002/0072768, Office Action, May 24, 2006.
2002/0072768, Office Action, Oct. 26, 2006.
2002/0072768, Office Action, Apr. 19, 2007.
2002/0133193, Office Action, Nov. 4, 2004.
2002/0133193, Office Action, May 4, 2005.
2002/0133193, Office Action, Oct. 18, 2005.
2002/0133193, Notice of Allowance, Apr. 18, 2007.
2002/0133193, Notice of Allowance, Sep. 27, 2007.
2003/0078598, Office Action, Feb. 9, 2005.
2003/0078598, Office Action, May 26, 2005.
2003/0078598, Office Action, Oct. 4, 2005.
2003/0078598, Notice of Allowance, May 10, 2006.
2003/0078598, Notice of Allowance, Jul. 2, 2007.
2003/0195561, Office Action, Jun. 10, 2004.
2003/0195561, Notice of Allowance, Sep. 21, 2004.
2003/0195561, Office Action, Jan. 3, 2006.
2003/0195561, Issue Notification, Feb. 15, 2006.
2003/0195561, Office Action, May 16, 2006.
2003/0195561, Notice of Allowance, Dec. 28, 2006.
2003/0195561, Notice of Allowance, Jul. 10, 2007.
2003/0195561, Notice of Allowance, Aug. 2, 2007.
2004/0153123, Office Action, Sep. 22, 2006.
2004/0153123, Office Action, Jan. 31, 2007.
2004/0153123, Office Action, Sep. 18, 2007.
2004/0153122, Office Action, Nov. 30, 2005.
2004/0153122, Office Action, Aug. 23, 2006.
2004/0153122, Office Action, Feb. 13, 2007.
2004/0153122, Office Action, Sep. 12, 2007.
2004/0073255, Office Action, Sep. 15, 2006.
2004/0073255, Office Action, Apr. 18, 2007.
2004/0073236, Office Action, Sep. 19, 2006.
2004/0073236, Office Action, May 2, 2007.
2004/0009289, Office Action, Jun. 30, 2006.
2004/0009289, Office Action, Oct. 20, 2006.
2004/0009289, Office Action, May 29, 2007.
2005/0274768, Office Action, Oct. 19, 2006.
2005/0274768, Office Action, Aug. 10, 2007.
2005/0216057, Office Action, Feb. 6, 2007.
2005/0216057, Office Action, May 30, 2007.
2005/0234508, Office Action, Aug. 13, 2007.
2006/0135989, Office Action, Nov. 30, 2006.
2006/0135989, Office Action, Sep. 5, 2007.
2006/0195124, Office Action, Jun. 6, 2007.
2006/0195123, Office Action, May 14, 2007.
6,197,042, Notice of Allowance, Nov. 6, 2000.
6,197,042, Issue Notification, Feb. 15, 2001.
6,277,140, Office Action, Mar. 26, 2001.
6,277,140, Notice of Allowance, Jun. 4, 2001.
6,277,140, Issue Notification, Aug. 6, 2001.
6,391,048, Notice of Allowance, Mar. 26, 2001.
6,391,048, Office Action, Sep. 5, 2001.
6,391,048, Notice of Allowance, Feb. 11, 2002.
6,391,048, Issue Notification, May 3, 2002.
6,461,364, Notice of Allowance, May 6, 2002.
6,461,364, Issue Notification, Sep. 19, 2002.
6,582,452, Notice of Allowance, Jan. 31, 2003.
6,582,452, Issue Notification, Jun. 5, 2003.
6,616,686, Office Action, Dec. 17, 2002.
6,616,686, Notice of Allowance, Apr. 21, 2003.
6,616,686, Issue Notification, Aug. 21, 2003.
6,623,510, Notice of Allowance, Apr. 11, 2003.
6,623,510, Office Action, Jun. 9, 2003.
6,623,510, Issue Notification, Sep. 4, 2003.
6,632,238, Office Action, Feb. 26, 2003.
6,632,238, Notice of Allowance, Jun. 16, 2003.
6,632,238, Issue Notification, Sep. 25, 2003.
6,669,714, Office Action, Mar. 4, 2003.
6,669,714, Notice of Allowance, Jul. 28, 2003.
6,669,714, Issue Notification, Dec. 11, 2003.
6,695,867, Notice of Allowance, Sep. 29, 2003.
6,695,867, Issue Notification, Feb. 5, 2004.
6,719,777, Office Action, Feb. 20, 1987.
6,719,777, Notice of Allowance, Jul. 24, 1987.
6,719,777, Issue Notification, Mar. 25, 2004.
6,749,621, Notice of Allowance, Feb. 9, 2004.
6,749,621, Office Action, Apr. 13, 2004.
6,749,621, Issue Notification, May 27, 2004.
6,780,197, Office Action, Sep. 11, 2003.
6,780,197, Office Action, Feb. 9, 2004.
6,780,197, Notice of Allowance, Mar. 17, 2004.
6,780,197, Issue Notification, Aug. 5, 2004.
6,926,731, Office Action, Nov. 16, 2004.
6,926,731, Notice of Allowance, Apr. 6, 2005.
6,926,731, Issue Notification, Jul. 20, 2005.
6,942,674, Office Action, Sep. 29, 2004.
6,942,674, Notice of Allowance, May 13, 2005.
6,942,674, Issue Notification, Aug. 24, 2005.
7,001,398, Office Action, Mar. 22, 2005.
7,001,398, Notice of Allowance, Jul. 6, 2005.
7,001,398, Notice of Allowance, Oct. 5, 2005.
7,001,398, Issue Notification, Feb. 21, 2006.
7,008,435, Office Action, Apr. 20, 2005.
7,008,435, Office Action, Aug. 10, 2005.
7,008,435, Notice of Allowance, Oct. 18, 2005.
7,008,435, Issue Notification, Feb. 15, 2006.
7,108,709, Office Action, Jul. 27, 2004.
7,108,709, Office Action, Dec. 17, 2004.
7,108,709, Notice of Allowance, Mar. 9, 2005.
7,108,709, Office Action, Aug. 11, 2006.
7,108,709, Issue Notification, Aug. 30, 2006.
7,111,768, Office Action, Feb. 23, 2006.
7,111,768, Notice of Allowance, May 31, 2006.
7,111,768, Issue Notification, Sep. 6, 2006.
7,163,551, Office Action, Jan. 10, 2006.
7,163,551, Notice of Allowance, Sep. 20, 2006.
7,163,551, Issue Notification, Dec. 27, 2006.
7,211,101, Office Action, Aug. 10, 2005.
7,211,101, Office Action, Dec. 19, 2005.
7,211,101, Office Action, Apr. 21, 2006.
7,211,101, Notice of Allowance, Dec. 27, 2006.
7,211,101, Issue Notification, Apr. 11, 2007.
2006/0144479, Office Action, Oct. 16, 2007.
Stretch Comb by Scunci, retrieved via internet at www.scunci.com/productdetail on Oct. 9, 2007, publication date unavailable.
U.S. Appl. No. 60/843,325, filed Sep. 8, 2006, Carly.
U.S. Appl. No. 60/946,030, filed Jun. 25, 2007, Voss et al.
U.S. Appl. No. 60/946,042, filed Jun. 25, 2007, Ellingwood et al.
U.S. Appl. No. 12/106,928, filed Apr. 21, 2008, Ginn et al.
U.S. Appl. No. 12/106,937, filed Apr. 21, 2008, Ginn et al.
U.S. Appl. No. 12/113,092, filed Apr. 30, 2008, Ginn et al.
U.S. Appl. No. 12/113,851, filed May 1, 2008, Coleman et al.
U.S. Appl. No. 12/114,031, filed May 2, 2008, Coleman et al.
U.S. Appl. No. 12/114,091, filed May 2, 2008, Coleman et al.
U.S. Appl. No. 12/143,020, filed Jun. 20, 2008, Ellingwood et al.
U.S. Appl. No. 10/006,400, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/147,774, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/147,774, Jun. 30, 2008, Office Action.
U.S. Appl. No. 10/264,306, May 26, 2005, Office Action.
U.S. Appl. No. 10/264,306, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jun. 27, 2008, Office Action.
U.S. Appl. No. 10/356,214, Mar. 6, 2008, Office Action.
U.S. Appl. No. 10/435,104, Apr. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jan. 30, 2008, Office Action.
U.S. Appl. No. 10/541,083, May 5, 2008, Office Action.
U.S. Appl. No. 10/638,115, Feb. 7, 2008, Office Action.
U.S. Appl. No. 10/667,144, May 12, 2008, Office Action.
U.S. Appl. No. 10/682,459, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/787,073, Feb. 22, 2008, Office Action.
U.S. Appl. No. 11/113,549, Apr. 16, 2008, Office Action.
U.S. Appl. No. 11/152,562, May 13, 2008, Office Action.
U.S. Appl. No. 11/344,891, Apr. 29, 2008, Office Action.
U.S. Appl. No. 11/406,203, May 23, 2008, Notice of Allowance.
U.S. Appl. No. 11/411,925, Feb. 5, 2008, Office Action.
U.S. Appl. No. 12/393,877, filed Feb. 26, 2009, Ellingwood et al.
U.S. Appl. No. 12/402,398, filed Mar. 11, 2009, Carley et al.
U.S. Appl. No. 12/403,256, filed Mar. 12, 2009, Carley et al.
U.S. Appl. No. 12/403,277, filed Mar. 12, 2009, Coleman et al.
U.S. Appl. No. 60/696,069, filed Jul. 1, 2005, Pantages et al.
U.S. Appl. No. 60/946,026, filed Jun. 25, 2007, Ellingwood.
Deepak Mital et al, Renal Transplantation Without Sutures Using The Vascular Clipping System For Renal Artery And Vein Anastomosis—A New Technique, Transplantation Issue, Oct. 1996, pp. 1171-1173, vol. 62—No. 8, Section of Transplantation Surgery, Department of General Surgery, Rush-Presbyterian/St. Luke's Medical Center, Chigago, IL.
DL Wessel et al, Outpatient closure of the patent ductus arteriosus, Circulation, May 1988, pp. 1068-1071, vol. 77—No. 5, Department of Anesthesia, Children's Hospital, Boston, MA.
E Pikoulis et al, Arterial reconstruction with vascular clips is safe and quicker than sutured repair, Cardiovascular Surgery, Dec. 1998, pp. 573-578(6), vol. 6—No. 6, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD.
G Gershony et al, Novel vascular sealing device for closure of percutaneous vascular access sites, Cathet. Cardiovasc. Diagn., Jan. 1998, pp. 82-88, vol. 45.
H De Swart et al, A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites, American journal of cardiology, Aug. 1993, pp. 445-449, vol. 72—No. 5, Department of Cardiology, Academic Hospital Maastricht, The Netherlands.
Harrith M. Hasson M.D. , Laparoscopic Cannula Cone with Means for Cannula Stabilization and Wound Closure, The Journal of the American Association of Gynecologic Laparoscopists, May 1998, pp. 183-185, vol. 5—No. 2, Division of Obstetrics and Gynecology, University of Chicago, Chigago, IL.
J. Findlay et al, Carotid Arteriotomy Closure Using a Vascular Clip System, Neurosurgery, Mar. 1998, pp. 550-554, vol. 42—No. 3, Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Jeremy L Gilbert PhD, Wound Closure Biomaterials And Devices, Shock., Mar. 1999, p. 226, vol. 11—No. 3, Institution Northwestern University.
Jochen T. Cremer, MD, et al, Different approaches for minimally invasive closure of atrial septal defects, Ann. Thorac. Surg., Nov. 1998, pp. 1648-1652, vol. 67, a Division of Thoracic and Cardiovascular Surgery, Surgical Center, Hannover Medical School. Hannover, Germany.
K Narayanan et al, Simultaneous primary closure of four fasciotomy wounds in a single setting using the Sure-Closure device, Injury, Jul. 1996, pp. 449-451, vol. 27—No. 6, Department of Surgery, Mercy Hospital of Pittsburgh, PA.
MD Gonze et al, Complications associated with percutaneous closure devices, Conference: Annual Meeting of the Society for Clinical Vascular Surgery, The American journal of surgery, Mar. 1999, pp. 209-211, vol. 178, No. 3, Department of Surgery, Section of Vascular Surgery, Ochsner Medical Institutions, New Orleans, LA.
MD Hellinger et al, Effective peritoneal and fascial closure of abdominal trocar sites utilizing the Endo-Judge, J Laparoendosc Surg., Oct. 1996, pp. 329-332, vol. 6—No. 5, Orlando Regional Medical Center, FL.
Michael Gianturco, A Play on Catheterization, Forbes, Dec. 1996, p. 146, vol. 158—No. 15.
OM Elashry et al, Comparative clinical study of port-closure techniques following laparoscopic surgery, Department of Surgery, Mallickrodt Institute of Radiography, J Am Coll Surg., Oct. 1996, pp. 335-344, vol. 183—No. 4.
P M N Werker, et al, Review of facilitated approaches to vascular anastomosis surgery, Conference: Utrecht MICABG Workshop 2, The Annals of thoracic surgery, Apr. 1996, pp. S122-S127, vol. 63—No. 6, Department of Plastic, Reconstructive and Hand surgery, University Hospital Utrecht Netherlands Departments of Cardiology and Cardiopulmonary Surgery, Heart Lung Institute, Utrecht Netherlands.; Utrect University Hospital Utrecht Netherlands.
Peter Rhee MD et al, Use of Titanium Vascular Staples in Trauma, Journal of Trauma-Injury Infection & Critical Care, Dec. 1998, pp. 1097-1099, vol. 45—No. 6, Institution from the Department of Surgery, Washington Hospital Center, Washington DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
ProstarXL—Percutaneous Vascular Surgical Device, www.Archive.org, Jun. 1998, Original Publisher: http://prostar.com, may also be found at http://web.archive.org/web/19980630040429/www.perclose.com/html/prstrxl.html.
SA Beyer-Enke et al, Immediate sealing of arterial puncture site following femoropopliteal angioplasty: A prospective randomized trial, Cardiovascular And Interventional Radiology 1996, Nov.-Dec. 1996, pp. 406-410, vol. 19—No. 6, Gen Hosp North, Dept Dianost & Intervent Radiol, Nurnberg, Germany (Reprint).
Scott Hensley, Closing Wounds. New Devices seal arterial punctures in double time, Modern Healthcare (United States), Mar. 23, 2008, p. 48.
Sigmund Silber et al, A novel vascular device for closure of percutaneous arterial access sites, The American Journal of Cardiology, Apr. 1999, pp. 1248-1252, vol. 83—No. 8.
Simonetta Blengino et al, A Randomized Study of the 8 French Hemostatic Puncture Closure Device vs Manual Compression After Coronary Interventions, Journal of the American College of Cardiology, Feb. 1995, p. 262A, vol. 25.—No. 2, Supplement 1.
Swee Lian Tan, MD, PhD, FACS, Explanation of Infected Hemostatic Puncture Closure Devices—A Case Report, Vascular and Endovascular Surgery, 1999, pp. 507-510, vol. 33—No. 5, Parkland Medical Center, Derry, New Hampshire.
Sy Nakada et al, Comparison of newer laparoscopic port closure techniques in the porcine model, J Endourol, Oct. 1995, pp. 397-401, vol. 9—No. 5, Department of Surgery/Urology, University of Wisconsin Medical School, Madison.
Thomas P. Baum RPA-C et al, Delayed Primary Closure Using Silastic Vessel Loops and Skin Staples: Description of the Technique and Case Reports, Annals of Plastic Surgery, Mar. 1999, pp. 337-340, vol. 42—No. 3, Institution Department of Plastic and Reconstructive Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
Tomoaki Hinohara, Percutaneous vascular surgery (Prostar® Plus and Techstar® for femoral artery site closure), Interventional Cardiology Newsletter, May-Jul. 1997, pp. 19-28, vol. 5—No. 3-4.
Ut Aker et al, Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device, Cathet Cardiovasc Diagn, Mar. 1994, pp. 228-232, vol. 33—No. 3, Missouri Baptist Medical Center, St. Louis.
Wei Qu et al, An absorbable pinned-ring device for microvascular anastomosis of vein grafts: Experimental studies, Microsurgery 1999, Mar. 1999, pp. 128-134, vol. 19—No. 3, Department of Orthopaedic Surgery, Hiroshima University School of Medicine, Hiroshima, Japan.
William G. Kussmaul III MD, et al., Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device, Journal of the American College of Cardiology, Jun. 1995, pp. 1685-1692, vol. 25—No. 7.
U.S. Appl. No. 10/006,400, Jan. 2, 2009, Office Action.
U.S. Appl. No. 10/264,306, Feb. 26, 2009, Office Action.
U.S. Appl. No. 10/305,923, Nov. 1, 2004, Office Action.
U.S. Appl. No. 10/305,923, Mar. 3, 2005, Notice of Allowance.
U.S. Appl. No. 10/356,214, Nov. 4, 2008, Office Action.
U.S. Appl. No. 10/435,104, Nov. 14, 2007, Supplemental Notice of Allowance.
U.S. Appl. No. 10/435,104, Sep. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Dec. 22, 2008, Supplemental Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 13, 2008, Notice of Allowance.
U.S. Appl. No. 10/517,004, Feb. 10, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Oct. 31, 2007, Office Action.
U.S. Appl. No. 10/541,083, Sep. 19, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Dec. 29, 2008, Notice of Allowance.
U.S. Appl. No. 10/616,832, Sep. 17, 2008, Office Action.
U.S. Appl. No. 10/638,115, Oct. 29, 2008, Office Action.
U.S. Appl. No. 10/682,459, Dec. 4, 2008, Office Action.
U.S. Appl. No. 10/787,073, Nov. 12, 2008, Office Action.
U.S. Appl. No. 10/908,721, Nov. 25, 2008, Office Action.
U.S. Appl. No. 11/152,562, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/198,811, Aug. 26, 2008, Office Action.
U.S. Appl. No. 11/344,793, Jan. 22, 2009, Office Action.
U.S. Appl. No. 11/344,891, Dec. 8, 2008, Office Action.
U.S. Appl. No. 11/344,891, Feb. 26, 2009, Office Action.
U.S. Appl. No. 11/396,731, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/406,203, Sep. 22, 2008, Notice of Allowance.
U.S. Appl. No. 11/411,925, Jan. 12, 2009, Office Action.
U.S. Appl. No. 11/427,297, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/461,323, May 2, 2007, Office Action.
U.S. Appl. No. 11/461,323, Oct. 29, 2007, Office Action.
U.S. Appl. No. 11/461,323, Apr. 25, 2008, Office Action.
U.S. Appl. No. 11/461,323, Nov. 6, 2008, Office Action.
U.S. Appl. No. 11/744,089, Nov. 26, 2008, Office Action.
U.S. Appl. No. 12/106,928, Jan. 23, 2009, Office Action.
U.S. Appl. No. 29/296,370, Aug. 18, 2008, Office Action.
U.S. Appl. No. 29/296,370, Dec. 2, 2008, Notice of Allowance.
McCarthy, et al., “Tension (Stay) Suture Bridge”, J. of International College of Surgeons, 34(5), pp. 613-614 (Nov. 1960).
U.S. Appl. No. 09/680,837, Jul. 9, 2002, Office Action.
U.S. Appl. No. 09/680,837, Nov. 6, 2002, Office Action.
U.S. Appl. No. 09/680,837, Mar. 25, 2003, Office Action.
U.S. Appl. No. 09/680,837, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/680,837, Sep. 11, 2003, Issue Notification.
U.S. Appl. No. 10/006,400, Jul. 9, 2009, Notice of Allowance.
U.S. Appl. No. 10/147,774, Mar. 18, 2009, Office Action.
U.S. Appl. No. 10/264,306, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/356,214, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/517,004, Jun. 26, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Apr. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/616,832, Jul. 21, 2009, Office Action.
U.S. Appl. No. 10/638,115, May 7, 2009, Notice of Allowance.
U.S. Appl. No. 10/667,144, Mar. 24, 2009, Office Action.
U.S. Appl. No. 10/669,313, Jan. 11, 2006, Notice of Allowance.
U.S. Appl. No. 10/669,313, Jun. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/669,313, Nov. 15, 2006, Issue Notification.
U.S. Appl. No. 10/682,459, Jun. 10, 2009, Office Action.
U.S. Appl. No. 10/787,073, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/908,721, Jun. 23, 2009, Office Action.
U.S. Appl. No. 11/048,503, Mar. 13, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jun. 26, 2009, Office Action.
U.S. Appl. No. 11/113,549, Jul. 21, 2009, Office Action.
U.S. Appl. No. 11/152,562, Jul. 6, 2009, Office Action.
U.S. Appl. No. 11/198,811, Sep. 22, 2009, Office Action.
U.S. Appl. No. 11/344,868, Mar. 25, 2009, Office Action.
U.S. Appl. No. 11/396,141, May 22, 2009, Restriction Requirement.
U.S. Appl. No. 11/396,141, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/396,731, May 22, 2009, Office Action.
U.S. Appl. No. 11/406,203, Mar. 3, 2009, Office Action.
U.S. Appl. No. 11/406,203, Sep. 16, 2009, Office Action.
U.S. Appl. No. 11/411,925, Sep. 10, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2009, Office Action.
U.S. Appl. No. 11/461,323, Jul. 27, 2009, Office Action.
U.S. Appl. No. 11/532,325, Feb. 23, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jun. 17, 2009, Office Action.
U.S. Appl. No. 11/744,089, Aug. 14, 2009, Office Action.
U.S. Appl. No. 11/958,295, Aug. 27, 2009, Office Action.
U.S. Appl. No. 12/106,937, Mar. 30, 2009, Office Action.
U.S. Appl. No. 29/296,370, Apr. 1, 2009, Notice of Allowance.
U.S. Appl. No. 12/481,377, Jan. 3, 2012, Office Action.
U.S. Appl. No. 12/548,274, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/684,562, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/608,769, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/684,400, Feb. 13, 2012, Office Action.
U.S. Appl. No. 12/724,304, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/402,398, Mar. 13, 2013, Notice of Allowance.
U.S. Appl. No. 13/028,041, Jan. 4, 2013, Office Action.
U.S. Appl. No. 13/028,041, Feb. 26, 2013, Office Action.
U.S. Appl. No. 12/114,031, Mar. 6, 2012, Office Action.
U.S. Appl. No. 12/684,470, Mar. 23, 2012, Office Action.
U.S. Appl. No. 12/688,065, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/897,358, Mar. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/973,204, Mar. 7, 2012, Notice of Allowance.
U.S. Appl. No. 12/987,792, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/113,851, Mar. 29, 2012, Office Action.
U.S. Appl. No. 12/403,277, Apr. 3, 2012, Office Action.
U.S. Appl. No. 11/675,462, Aug. 16, 2012, Issue Notification.
U.S. Appl. No. 11/744,089, Aug. 8, 2012, Office Action.
U.S. Appl. No. 12/481,377, Aug. 10, 2012, Notice of Allowance.
U.S. Appl. No. 12/850,242, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/955,859, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/548,274, Sep. 10, 2012, Office Action.
U.S. Appl. No. 12/684,470, Aug. 30, 2012, Office Action.
U.S. Appl. No. 12/684,542, Sep. 13, 2012, Office Action.
U.S. Appl. No. 12/402,398, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 12, 2012, Office Action.
U.S. Appl. No. 12/848,642, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/987,792, Sep. 17, 2012, Office Action.
U.S. Appl. No. 10/667,144, Oct. 28, 2011, Notice of Allowance.
U.S. Appl. No. 12/945,646, Oct. 26, 2011, Office Action.
U.S. Appl. No. 11/427,297, Oct. 31, 2012, Issue Notification.
U.S. Appl. No. 12/114,091, Nov. 8, 2012, Office Action.
U.S. Appl. No. 12/403,277, Nov. 5, 2012, Office Action.
U.S. Appl. No. 12/608,769, Nov. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/684,400, Oct. 16, 2012, Office Action.
U.S. Appl. No. 12/848,642, Nov. 9, 2012, Office Action.
U.S. Appl. No. 12/850,242, Oct. 17, 2012, Office Action.
U.S. Appl. No. 13/039,087, Nov. 6, 2012, Notice of Allowance.
U.S. Appl. No. 12/393,877, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/941,809, Dec. 13, 2011, Restriction Requirement.
U.S. Appl. No. 12/338,977, Jan. 19, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jan. 27, 2012, Office Action.
U.S. Appl. No. 11/344,891, Jan. 22, 2013, Notice of Allowance.
U.S. Appl. No. 13/030,922, Jan. 31, 2013, Office Action.
U.S. Appl. No. 13/153,594, Jan. 29, 2013, Office Action.
U.S. Appl. No. 13/615,547, Jan. 18, 2013, Office Action.
U.S. Appl. No. 11/767,818, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/684,542, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/966,923, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/961,331, Feb. 1, 2013, Office Action.
U.S. Appl. No. 13/488,233, Feb. 5, 2013, Notice of Allowance.
U.S. Appl. No. 10/667,144, Feb. 15, 2012, Issue Notification.
U.S. Appl. No. 12/135,858, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/684,562, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/945,646, Feb. 21, 2012, Notice of Allowance.
U.S. Appl. No. 12/143,020, Feb. 23, 2012, Notice of Allowance.
U.S. Appl. No. 12/548,274, Mar. 2, 2012, Office Action.
U.S. Appl. No. 12/642,319, Feb. 27, 2012, Office Action.
U.S. Appl. No. 12/114,091, Apr. 5, 2012, Office Action.
U.S. Appl. No. 12/684,542, Apr. 16, 2012, Office Action.
U.S. Appl. No. 11/744,089, Apr. 15, 2013, Office Action.
U.S. Appl. No. 12/850,242, Apr. 18, 2013, Office Action.
U.S. Appl. No. 13/052,634, Feb. 8, 2013, Office Action.
U.S. Appl. No. 13/052,634, Apr. 22, 2013, Office Action.
U.S. Appl. No. 13/615,547, Apr. 12, 2013, Notice of Allowance.
U.S. Appl. No. 13/308,227, filed Nov. 30, 2011, Yibarren.
U.S. Appl. No. 12/688,065, Apr. 26, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jan. 7, 2013, Office Action.
U.S. Appl. No. 13/490,143, Jan. 4, 2013, Office Action.
U.S. Appl. No. 12/897,358, Jan. 12, 2012, Notice of Allowance.
U.S. Appl. No. 11/390,586, May 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/684,400, May 9, 2012, Office Action.
U.S. Appl. No. 12/897,358, May 2, 2012, Issue Notification.
U.S. Appl. No. 12/966,923, May 16, 2012, Issue Notification.
U.S. Appl. No. 11/344,891, May 15, 2013, Issue Notification.
U.S. Appl. No. 12/955,859, May 16, 2013, Office Action.
U.S. Appl. No. 13/488,233, May 15, 2013, Issue Notification.
U.S. Appl. No. 13/898,202, filed May 20, 2013, Walberg et al.
U.S. Appl. No. 13/153,594, May 29, 2013, Office Action.
U.S. Appl. No. 13/791,829, May 29, 2013, Office Action.
U.S. Appl. No. 13/525,839, filed Jun. 18, 2012, Carley et al.
U.S. Appl. No. 11/427,297, Jun. 26, 2012, Notice of Allowance.
U.S. Appl. No. 11/767,818, Jul. 4, 2012, Issue Notification.
U.S. Appl. No. 12/338,977, Jul. 11, 2012, Office Action.
U.S. Appl. No. 11/390,586, Jul. 18, 2012, Issue Notification.
U.S. Appl. No. 12/608,773, Jul. 20, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jul. 30, 2012, Office Action.
U.S. Appl. No. 13/039,087, Jul. 17, 2012, Office Action.
U.S. Appl. No. 12/338,977, Nov. 28, 2012, Office Action.
U.S. Appl. No. 12/961,331, Dec. 4, 2012, Office Action.
U.S. Appl. No. 13/030,922, Dec. 18, 2012, Office Action.
U.S. Appl. No. 12/955,859, Dec. 15, 2011, Office Action.
U.S. Appl. No. 10/616,832, Jan. 26, 2011, Issue Notification.
U.S. Appl. No. 11/152,562, Jan. 26, 2011, Issue Notification.
U.S. Appl. No. 13/017,636, filed Jan. 31, 2011, Carley et al.
U.S. Appl. No. 13/026,989, filed Feb. 14, 2011, Cummins.
U.S. Appl. No. 10/264,306, Feb. 16, 2011, Issue Notification.
U.S. Appl. No. 11/767,818, Feb. 16, 2011, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2011, Office Action.
U.S. Appl. No. 12/481,377, Apr. 28, 2011, Office Action.
U.S. Appl. No. 13/153,594, filed Jun. 6, 2011, Reyes et al.
U.S. Appl. No. 10/667,144, Jun. 6, 2011 Office Action.
U.S. Appl. No. 12/481,377, Jun. 21, 2011, Office Action.
U.S. Appl. No. 12/114,091, Jul. 7, 2011, Office Action.
U.S. Appl. No. 12/945,646, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/135,858, Jul. 13, 2011, Office Action.
U.S. Appl. No. 10/435,104, Jul. 23, 2009, Notice of Allowance.
U.S. Appl. No. 10/669,313, Oct. 31, 2005, Office Action.
U.S. Appl. No. 11/113,549, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/959,334, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 12/403,277, Jul. 8, 2010, Office Action.
U.S. Appl. No. 12/113,851, Dec. 16, 2010, Office Action.
U.S. Appl. No. 12/114,091, Dec. 17, 2010, Office Action.
U.S. Appl. No. 13/791,829, filed Mar. 8, 2013, Roorda et al.
U.S. Appl. No. 13/791,846, filed Mar. 8, 2013, Palermo.
U.S. Appl. No. 13/112,618, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,631, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/308,227, Apr. 10, 2013, Office Action.
U.S. Appl. No. 13/525,839, Apr. 1, 2013, Office Action.
U.S. Appl. No. 11/396,141, Apr. 30, 2013, Office Action.
U.S. Appl. No. 11/852,190, Apr. 24, 2013, Office Action.
U.S. Appl. No. 12/848,642, Apr. 26, 2013, Office Action.
U.S. Appl. No. 13/490,143, Apr. 29, 2013, Notice of Allowance.
U.S. Appl. No. 12/143,020, May 30, 2012, Issue Notification.
U.S. Appl. No. 12/393,877, May 21, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jun. 1, 2012, Office Action.
U.S. Appl. No. 12/945,646, May 30, 2012, Issue Notification.
U.S. Appl. No. 12/973,204, May 30, 2012, Issue Notification.
U.S. Appl. No. 11/427,309, Jun. 7, 2013, Notice of Allowance.
U.S. Appl. No. 13/112,618, Jun. 7, 2013, Office Action.
U.S. Appl. No. 13/488,233, Jun. 5, 2013, Issue Notification.
U.S. Appl. No. 12/608,733, Jun. 7, 2012, Office Action.
U.S. Appl. No. 13/026,989, Jun. 8, 2012, Office Action.
U.S. Appl. No. 12/338,977, Jun. 19, 2013, Office Action.
U.S. Appl. No. 12/608,769, Aug. 22, 2012, Office Action.
U.S. Appl. No. 12/642,319, Aug. 28, 2012, Office Action.
U.S. Appl. No. 12/684,562, Aug. 21, 2012, Office Action.
U.S. Appl. No. 13/026,989, Sep. 16, 2011, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2011, Office Action.
U.S. Appl. No. 12/393,877, Sep. 29, 2011, Office Action.
U.S. Appl. No. 12/684,470, Dec. 20, 2011, Restriction Requirement.
U.S. Appl. No. 12/684,569, Dec. 20, 2011, Restriction Requirement.
U.S. Appl. No. 11/675,462, Dec. 22, 2011, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 22, 2010, Issue Notification.
U.S. Appl. No. 12/941,809, filed Nov. 8, 2010, Ginn et al.
U.S. Appl. No. 12/950,628, filed Nov. 19, 2010, Walberg et al.
U.S. Appl. No. 12/955,859, filed Nov. 29, 2010, Ginn.
U.S. Appl. No. 12/945,646, filed Nov. 12, 2010, Carley et al.
U.S. Appl. No. 12/973,204, filed Dec. 20, 2010, Jabba et al.
U.S. Appl. No. 12/987,792, filed Jan. 10, 2011, Palermo et al.
U.S. Appl. No. 10/435,104, Jan. 12, 2011, Issue Notification.
U.S. Appl. No. 12/402,398, Jan. 24, 2011, Office Action.
U.S. Appl. No. 12/945,646, Jan. 20, 2011, Office Action.
U.S. Appl. No. 13/039,087, filed Mar. 2, 2011, Palermo et al.
U.S. Appl. No. 11/852,190, Mar. 2, 2011, Office Action.
U.S. Appl. No. 12/122,603, Mar. 3, 2011, Office Action.
U.S. Appl. No. 11/958,281, Mar. 10, 2011, Office Action.
U.S. Appl. No. 11/532,576, Mar. 16, 2011, Issue Notification.
U.S. Appl. No. 11/396,731, Mar. 22, 2011, Office Action.
U.S. Appl. No. 11/427,297, Mar. 21, 2011, Office Action.
U.S. Appl. No. 10/682,459, Apr. 1, 2011, Notice of Allowance.
U.S. Appl. No. 12/403,277, Mar. 31, 2011, Office Action.
U.S. Appl. No. 13/028,041, filed Feb. 15, 2011, Von Oepen.
U.S. Appl. No. 13/112,618, filed May 20, 2011, Gianotti et al.
U.S. Appl. No. 13/112,631, filed May 20, 2011, Voss.
U.S. Appl. No. 12/955,859, May 26, 2011, Office Action.
U.S. Appl. No. 60/711,279, filed Aug. 24, 2005, Sibbitt Jr. et al.
U.S. Appl. No. 60/726,985, filed Oct. 14, 2005, Sibbitt Jr. et al.
U.S. Appl. No. 61/097,072, filed Sep. 15, 2008, Sibbitt Jr. et al.
U.S. Appl. No. 11/316,775, Apr. 16, 2008, Office Action.
U.S. Appl. No. 11/316,775, Aug. 6, 2008, Office Action.
U.S. Appl. No. 11/406,203, Jun. 18, 2010, Notice of Allowance.
U.S. Appl. No. 11/508,656, Dec. 9, 2009, Office Action.
U.S. Appl. No. 11/508,656, Mar. 25, 2010, Office Action.
U.S. Appl. No. 11/508,662, Dec. 28, 2009, Office Action.
U.S. Appl. No. 11/508,662, Apr. 14, 2010, Office Action.
U.S. Appl. No. 11/508,715, Jan. 6, 2010, Office Action.
U.S. Appl. No. 11/508,715, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/958,295, May 25, 2010, Office Action.
U.S. Appl. No. 12/402,398, May 20, 2010, Office Action.
U.S. Appl. No. 10/147,774, Apr. 6, 2011, Issue Notification.
U.S. Appl. No. 12/122,603, Apr. 22, 2011, Office Action.
U.S. Appl. No. 10/147,774, Jun. 8, 2010, Office Action.
U.S. Appl. No. 10/264,306, Jun. 15, 2010, Office Action.
U.S. Appl. No. 10/435,104, Jun. 2, 2010, Office Action.
U.S. Appl. No. 10/667,144, Jun. 22, 2010, Office Action.
U.S. Appl. No. 11/198,811, Jun. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/390,586, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/396,731, Jun. 29, 2010, Office Action.
U.S. Appl. No. 11/852,190, Jun. 24, 2010, Office Action.
U.S. Appl. No. 12/113,851, Jun. 24, 2010, Office Action.
U.S. Appl. No. 12/955,859, Jul. 21, 2011, Office Action.
U.S. Appl. No. 60/793,444, filed Apr. 20, 2006, Jones et al.
U.S. Appl. No. 60/693,531, filed Jun. 24, 2005, Carly.
U.S. Appl. No. 61/139,995, filed Dec. 22, 2008, Clark.
U.S. Appl. No. 61/141,597, filed Dec. 30, 2008, Clark.
U.S. Appl. No. 12/481,377, filed Jun. 9, 2009, Clark.
U.S. Appl. No. 12/642,319, filed Dec. 18, 2009, Clark.
Marshall A.C., Lock J.E., Structural and Compliant Anatomy of the Patent Foramen Ovale in Patients Undergoing Transcatheter Closure, Am Heart J Aug. 2000; 140(2); pp. 303-307.
Taber's Cyclopedic Medical Dictionary, 18th Ed. 1997, pp. 747 and 1420.
U.S. Appl. No. 10/006,400, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Apr. 27, 2010, Notice of Allowance.
U.S. Appl. No. 10/147,774, Oct. 26, 2009, Office Action.
U.S. Appl. No. 10/264,306, Jan. 27, 2010, Office Action.
U.S. Appl. No. 10/356,214, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Apr. 23, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Feb. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Sep. 30, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 1, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/667,144, Nov. 23, 2009, Office Action.
U.S. Appl. No. 10/682,459, Dec. 23, 2009, Office Action.
U.S. Appl. No. 10/682,459, Apr. 28, 2010, Office Action.
U.S. Appl. No. 10/787,073, Feb. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/908,721, Feb. 2, 2010, Office Action.
U.S. Appl. No. 11/048,503, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Apr. 26, 2010, Notice of Allowance.
U.S. Appl. No. 11/152,562, Mar. 31, 2010, Office Action.
U.S. Appl. No. 11/344,891, Oct. 7, 2009, Office Action.
U.S. Appl. No. 11/396,141, May 4, 2010, Office Action.
U.S. Appl. No. 11/455,993, Feb. 17, 2009, Office Action.
U.S. Appl. No. 11/455,993, Dec. 16, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jan. 5, 2010, Office Action.
U.S. Appl. No. 11/532,576, Mar. 1, 2010, Office Action.
U.S. Appl. No. 11/532,576, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/674,930, Jan. 8, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jun. 4, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jan. 8, 2010, Office Action.
U.S. Appl. No. 11/675,462, Dec. 10, 2009, Office Action.
U.S. Appl. No. 11/767,818, Dec. 24, 2009, Office Action.
U.S. Appl. No. 11/767,818, Mar. 22, 2010, Office Action.
U.S. Appl. No. 11/959,334, Aug. 19, 2009, Office Action.
U.S. Appl. No. 11/959,334, Jan. 12, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Apr. 14, 2010, Notice of Allowance.
U.S. Appl. No. 12/106,937, Nov. 18, 2009, Office Action.
U.S. Appl. No. 12/106,928, Oct. 5, 2009, Office Action.
U.S. Appl. No. 12/402,398, Mar. 9, 2010, Office Action.
U.S. Appl. No. 12/403,256, Dec. 16, 2009, Office Action.
U.S. Appl. No. 12/403,256, Mar. 30, 2010, Office Action.
U.S. Appl. No. 29/296,370, Feb. 10, 2010, Issue Notification.
U.S. Appl. No. 10/541,083, May 10, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, May 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, May 13, 2010, Notice of Allowance.
U.S. Appl. No. 11/390,586, Jun. 24, 2009, Office Action.
U.S. Appl. No. 10/682,459, Aug. 10, 2011, Issue Notification.
U.S. Appl. No. 11/508,656, Aug. 30, 2010, Office Action.
U.S. Appl. No. 11/675,462, Aug. 31, 2010, Office Action.
U.S. Appl. No. 11/958,281, Sep. 2, 2010, Office Action.
U.S. Appl. No. 10/616,832, Sep. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Sep. 15, 2010, Issue Notification.
U.S. Appl. No. 11/152,562, Sep. 16, 2010, Notice of Allowance.
U.S. Appl. No. 11/427,297, Sep. 15, 2010, Office Action.
U.S. Appl. No. 11/767,818, Sep. 30, 2010, Office Action.
U.S. Appl. No. 12/365,397, Sep. 13, 2010, Office Action.
U.S. Appl. No. 12/114,031, May 11, 2011, Office Action.
U.S. Appl. No. 12/143,020, May 11, 2011, Office Action.
U.S. Appl. No. 11/344,891, May 7, 2010, Office Action.
U.S. Appl. No. 12/106,928, May 10, 2010, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2010, Office Action.
U.S. Appl. No. 13/030,922, filed Feb. 18, 2011, Cummins.
U.S. Appl. No. 10/356,214, Feb. 23, 2011, Issue Notification.
U.S. Appl. No. 11/113,549, Jan. 4, 2011, Office Action.
U.S. Appl. No. 11/675,462, Aug. 3, 2011, Office Action.
U.S. Appl. No. 12/114,031, Aug. 2, 2011, Office Action.
U.S. Appl. No. 61/015,144, filed Dec. 19, 2007, Mackiewicz et al.
U.S. Appl. No. 61/109,822, filed Oct. 30, 2008, Mehl et al.
U.S. Appl. No. 61/143,748, filed Jan. 9, 2009, Mehl et al.
U.S. Appl. No. 61/143,751, filed Jan. 9, 2009, Voss et al.
U.S. Appl. No. 61/145,468, filed Jan. 16, 2009, Fortson, et al.
U.S. Appl. No. 09/610,128, filed Jul. 5, 2000, Kerievsky.
U.S. Appl. No. 12/548,274, filed Aug. 26, 2009, Clark.
U.S. Appl. No. 12/724,304, filed Mar. 15, 2010, Fortson.
U.S. Appl. No. 12/848,642, filed Aug. 2, 2010, Fortson et al.
U.S. Appl. No. 10/006,400, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Aug. 17, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Jul. 30, 2010, Notice of Allowance.
U.S. Appl. No. 11/427,309, May 28, 2008, Office Action.
U.S. Appl. No. 11/427,309, Jan. 2, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 20, 2009, Office Action.
U.S. Appl. No. 11/427,309, Nov. 6, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/757,108, Nov. 25, 2009, Office Action.
U.S. Appl. No. 13/222,899, filed Aug. 31, 2011, Carley et al.
U.S. Appl. No. 12/143,020, Aug. 31, 2011, Office Action.
U.S. Appl. No. 12/897,358, Aug. 22, 2011, Office Action.
U.S. Appl. No. 11/396,731, Sep. 1, 2011, Office Action.
U.S. Appl. No. 09/866,551, filed May 25, 2001, Ginn.
U.S. Appl. No. 10/638,115, Aug. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Aug. 25, 2010, Notice of Allowance.
U.S. Appl. No. 12/403,256, Aug. 19, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, Sep. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Oct. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/682,459, Oct. 12, 2010, Office Action.
U.S. Appl. No. 11/406,203, Oct. 6, 2010, Issue Notification.
U.S. Appl. No. 11/532,576, Oct. 13, 2010, Notice of Allowance.
U.S. Appl. No. 11/958,281, Oct. 8, 2010, Office Action.
U.S. Appl. No. 12/114,031, Oct. 5, 2010, Office Action.
U.S. Appl. No. 12/403,277, Oct. 12, 2010, Office Action.
U.S. Appl. No. 11/508,715, Oct. 18, 2010, Office Action.
U.S. Appl. No. 10/264,306, Oct. 29, 2010, Notice of Allowance.
U.S. Appl. No. 12/106,928, Oct. 25, 2010, Office Action.
U.S. Appl. No. 11/198,811, Oct. 20, 2010, Issue Notification.
U.S. Appl. No. 11/508,662, Oct. 26, 2010, Office Action.
U.S. Appl. No. 11/852,190, Nov. 1, 2010, Office Action.
U.S. Appl. No. 12/114,091, Oct. 27, 2010, Office Action.
U.S. Appl. No. 11/427,309, Nov. 15, 2010, Office Action.
U.S. Appl. No. 12/961,331, filed Dec. 6, 2010, Voss.
U.S. Appl. No. 10/147,774, Dec. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Nov. 23, 2010, Issue Notification.
U.S. Appl. No. 10/541,083, Dec. 1, 2010, Issue Notification.
U.S. Appl. No. 11/959,334, Nov. 10, 2010, Issue Notification.
U.S. Appl. No. 12/114,031, Nov. 22, 2010, Office Action.
U.S. Appl. No. 12/403,256, Nov. 23, 2010, Issue Notification.
U.S. Appl. No. 12/897,358, filed Oct. 4, 2010, Carley.
U.S. Appl. No. 12/966,923, filed Dec. 13, 2010, Cummins et al.
U.S. Appl. No. 11/048,503, Dec. 8, 2010, Issue Notification.
U.S. Appl. No. 13/112,631, Jun. 26, 2013, Office Action.
U.S. Appl. No. 11/344,891, Jun. 26, 2013, Issue Notification.
U.S. Appl. No. 12/106,928, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,937, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/402,398, Jun. 26, 2013, Issue Notification.
U.S. Appl. No. 12/941,809, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/961,331, Jul. 3, 2013, Office Action.
U.S. Appl. No. 10/908,721, Jul. 18, 2013, Notice of Allowance.
U.S. Appl. No. 11/396,141, Aug. 21, 2013, Office Action.
U.S. Appl. No. 11/427,309, Sep. 25, 2013, Issue Notification.
U.S. Appl. No. 11/744,089, Aug. 8, 2013, Notice of Allowance.
U.S. Appl. No. 12/850,242, Aug. 6, 2013, Notice of Allowance.
U.S. Appl. No. 12/955,859, Aug. 1, 2013, Notice of Allowance.
U.S. Appl. No. 13/026,989, Aug. 23, 2013, Office Action.
U.S. Appl. No. 13/028,041, Aug. 21, 2013, Notice of Allowance.
U.S. Appl. No. 13/030,922, Jul. 18, 2013, Office Action.
U.S. Appl. No. 13/525,839, Jul. 15, 2013, Notice of Allowance.
U.S. Appl. No. 13/791,829, Oct. 8, 2013, Notice of Allowance.
Related Publications (1)
Number Date Country
20040167570 A1 Aug 2004 US
Continuations (1)
Number Date Country
Parent 10081725 Feb 2002 US
Child 10786444 US